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SUMMARY 
Secondary lymphoid organs (SLOs) are the sites where B and T lymphocytes 
encounter antigen and mount the adaptive immune response. Antigen specific B cells 
will first produce low affinity antibodies. Some B cells then enter the germinal center 
(GC) reaction, during which high affinity antibody bearing B cells are positively 
selected and undergo clonal expansion. An important cell type involved in the GC 
reaction is the follicular dendritic cell (FDC). During the GC reaction they present 
native antigen in form of immune complexes (ICs) to GC B cells, supplying high 
affinity B cells with essential survival factors, while low affinity B cells undergo 
apoptosis. FDCs furthermore produce Mfge8, a secreted protein needed for the 
removal of apoptotic GC B cells by tingible body macrophages (TBMs). FDCs have 
also an essential function before GCs occur – they establish T and B cell specific 
compartments of the SLOs, via the secretion of B cell specific chemokines and 
production of adhesion molecules.  
FDCs, however, not only exert beneficial functions during immune responses, 
they also show noxious effects during pathological conditions. FDCs can trap large 
amounts of infectious HIV on their surface, thereby facilitating the viral spread and 
accelerating the course of AIDS disease. In prion diseases, FDCs are not only the 
major source of prion particles in SLOs, their presence is also needed for prions to 
invade the central nervous system (CNS).  
Though much is known about the function of FDCs, little is understood about 
their origin. They are thought to be derived from a mesenchymal cell, as they express 
some fibroblast makers and show similarities to fibroblast reticular cells. However, 
the true founder cell remained as elusive as the question whether they are derived 
from a sessile or migratory cell. Development and maintenance of FDCs is based on 
the presence of B lymphocytes and signaling via the lymphotoxin beta receptor 
(LTR) and the tumor necrosis factor receptor 1 (TNFR1). 
Studying the ontogeny of FDCs I pinpointed down detailed signaling events 
and cell types needed for the stepwise maturation of this cell type. I revealed that 
putative precursors of FDCs were present at perivascular sites before follicular 
structures developed. While the first clustering of these cells was independent of 
LTR activation, I could show that the further maturation was lymphotoxin (LT) 
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driven. This process was mediated by a non-B cell expressing the common cytokine 
receptor gamma - the lymphoid tissue inducer cell (LTi). For FDCs to undergo final 
maturation, B cells and TNFR1 signaling were required.  
Since putative FDC precursors were first present at perivascular sites, I was 
interested to see whether mature FDCs are indeed derived from a cell residing along 
vascular structures. Pericytes are specialized cells enlacing vascular endothelial cells 
and were furthermore shown to be precursor cells of fibroblasts, muscle cells and fat 
tissue. One of the major hallmarks of pericytes is the expression of the platelet 
derived growth factor receptor (PDGFR). To test whether FDCs are derived from 
pericytes, I analyzed Pdgfrb reporter mice and found that reporter expression co-
localized with FDC markers. Taken together these results highly suggest a pericyte 
origin of FDCs and support the model that FDC like cells in vessel proximity are 
early FDCs.
The finding that FDCs are derived from perivascular cells expressing 
PDGFR in the spleen, probably pericytes, also gives insight into the de novo 
development of FDCs in non-lymphoid organs. Pericytes are a constitutive part of the 
vasculature in any organ. According to our hypothesis, while in future SLOs the 
differentiation of the local pericyte is induced by developmental cues giving 
‘instructions’ e.g. through innervations of the tissue, the pericyte in the place of non-
lymphoid organs usually remains ‘silent’ and does not transdifferentiate. However, 
the pericyte can become activated by a chronic inflammatory stimulus. The 
subsequent vascular remodeling results in the influx of lymphocytes and the 
differentiation of the pericyte into an FDC. Our model reunites the molecular and 
especially cellular mechanisms behind the development of the different SLOs, but 
also tertiary lymphoid organs (TLOs) in chronic inflammations, and is based on the 
presence of a cell common to all tissues, the pericyte. This insight will further help 
understanding the ontogeny of TLOs and the development of therapeutic strategies for 
chronic inflammatory and autoimmune diseases. 
The second part of my thesis deals with the generation of novel transgenic 
methods to target several FDC related questions. Transgenic mice with FDC specific 
expression of genes will be used to investigate the involvement of FDCs in 
pathological conditions, such as prion replication, the development of autoimmunity 
and chronic inflammation, but also to lineage trace early FDCs in SLOs and TLOs. 
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Currently I am generating bacterial artificial chromosome (BAC) transgenic mice 
using the Mfge8 promoter to drive the expression of following genes:  
- Mfge-Prnp, to restrict the prion protein to FDCs 
- Mfge8-Cre and Mfge8-CreERT2, mice which will allow to conditionally ablate, 
label and gene target FDCs 
- Mfge8-tdTomato, to fluorescently label cells actively expressing Mfge8, enabling 
their isolation 
- Mfge8-LT, to test whether FDCs can develop in an autocrine fashion in SLOs and 
generate TLOs. 
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ZUSAMMENFASSUNG 
 
In sekundären lymphatischen Organen (SLO) treten B und T Lymphozyten in Kontakt 
mit Antigen, und reagieren mit einer adaptiven Immunantwort darauf. Antigen-
spezifische B Zellen produzieren als erstes Antikörper mit geringer Affinität. Einige 
der aktivierten B Zellen wandern in sogenannte Keimzentren, wo es zur Selektion von 
B Lymphozyten mit grösserer Affinität und klonalen Vermehrung dieser kommt. Eine 
äusserst wichtige Zelle, die an der Keimzentrumsreaktion partizipiert, ist die 
follikuläre dendritische Zelle (FDC). Während diesem Vorgang präsentiert die FDC 
natives Antigen in Form von Immunkomplexen den B Lymphozyten, wobei nur die B 
Zellen mit hoher Affinität für das präsentierte Antigen mit ausreichenden 
Überlebenssignalen versorgt werden. Die Restlichen sterben durch Apoptose. FDCs 
sekretieren ausserdem das Protein Mfge8, das die Beseitigung apoptotischer B Zellen 
während der Keimzentrumsreaktion durch tingible-body Makrophagen (TBMs) 
ermöglicht. Eine weitere Funktion der FDCs besteht bereits vor der Entstehung 
solcher Keimzentren – sie ermöglichen die örtliche Trennung der SLOs in B und T 
Zellareale durch die Sekretion von B zellspezifischen Chemokinen sowie die 
Produktion von Zelladhäsionsmolekülen. 
 FDCs üben allerdings nicht nur gutartige Funktionen wie zum Beispiel 
während der Immunantwort aus, ihre Präsenz kann auch Nachteile in pathologischen 
Vorgängen haben. FDCs können grosse Mengen an infektiösem HIV an der 
Oberfläche binden und so zur Ausbreitung des Virus beitragen. In 
Prionenerkrankungen, stellen FDCs nicht nur die Hauptquelle von Prionen in SLOs 
dar, die Invasion des Nervensystems durch Prionen geschieht nur im Beisein dieser 
Zelle. 
 Obwohl einiges über die Funktion von FDCs bekannt ist, versteht man bisher 
wenig über deren Entstehung. Es gibt Indizien, dass sie einen mesenchymalen 
Ursprung haben, exprimieren sie doch Zellmarker spezifisch für Fibroblasten und 
zeigen eine Ähnlichkeit mit fibroblastischen Retikulumzellen. Bisher ist weder die 
eigentliche Zelle, aus der die FDC hervorgeht, bekannt, noch weiss man, ob sie von 
einer lokalen oder migratorischen Zelle abstammt. Die Entwicklung wie auch die 
Erhaltung von FDCs benötigt die Präsenz von B Zellen, Zellsignalisierung via den 
Lymphotoxin Rezeptor (LTR) und Tumor Necrosis Faktor Rezeptor 1 (TNFR1). 
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 Durch das Studium der Ontogenese von FDCs, konnte ich 
Zellsignalisierungsmechanismen und Zelltypen eruieren, welche die einzelnen 
Entwicklungsschritte dieser Zellen definierten. Es wurde deutlich, dass mögliche FDC 
Vorläuferzellen zuerst perivaskulär auftraten, noch bevor sich follikuläre Strukturen 
entwickelten. Diese erste Ansammlung von Zellen geschah unabhängig von einer 
Aktivierung des LTR. Die weitere Maturation hing allerdings von Lymphotoxinen 
ab. Dieser Prozess wurde durch die Präsenz einer Nicht-B Zelle, welche den ´common 
cytokine receptor gamma´ exprimiert, ermöglicht – die ´lymphoid tissue inducer´ 
Zelle (LTi). Für die vollständige Entwicklung der FDCs benötigte es aber sowohl B 
Zellen als auch TNFR1 Aktivität. 
 Meinen Untersuchungen hatten ergeben, dass sich FDC Vorläufer zuerst in 
nächster Nähe von Gefässen befinden. Deswegen war ich daran interessiert 
herauszufinden, ob vollständig differenzierte FDCs tatsächlich von perivaskulären 
Zellen abstammen könnten. Mein Augenmerk viel dabei auf Perizyten, spezialisierte 
Zellen welche das Gefässendothel umgeben. Perizyten haben ausserdem 
Vorläuferpotential und können Fibroblasten, Muskelzellen wie auch Fettzellen bilden. 
Ein Kennzeichen von Perizyten ist die Expression von ´Platelet-derived growth factor 
´ (PDGFR). Um festzustellen, ob FDCs von diesen Zellen abstammen könnten, 
analysierten wir Pdgfrb-Reportermäuse und stellten fest, dass das Expressionsmuster 
des Reporterproteins mit FDC Markern übereinstimmte. Alles in allem weisen diese 
Resultate sehr stark auf einen perizytischen Ursprung der FDC hin, und unterstützen 
das Model, in welchem FDC-ähnlichen Zellen in Gefässnähe frühe FDCs 
repräsentieren. 
 Die Erkenntnis, dass FDCs in der Milz von PDGFR positiven,perivaskulären 
Zellen - vermutlich Perizyten - abstammen, gibt auch Einblick in die de novo 
Entwicklung von FDCs in nicht-lymphatischen Organen. Perizyten sind ein fester 
Bestandteil eines jeden Gefässes, und deswegen in allen Organen vorhanden. Meine 
Hypothese besagt, dass im Falle von SLOs lokale Perizyten bereits während der 
Organentwicklung Schlüsselsignale – wie zum Beispiel durch die Innervierung des 
Gewebes – erhalten und dadurch zu FDCs differenzieren. Im Gegensatz dazu bleibt 
die Perizyte unter normalen Umständen in nicht-lymphatischen Organen ‚ruhend’ und 
beginnt keine Transdifferenzierung. Im Falle einer chronischen Entzündung, wird die 
Perizyte aktiviert. Dies führt zu Änderungen in der Gefässstruktur und ermöglicht das 
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Einströmen von Lymphozyten, was in der Ausdifferenizierung der Perizyte in FDCs 
resultiert. Unser Modell vereinheitlicht die molekularen und zellulären Mechanismen, 
die der Entwicklung der verschiedenen SLOs und auch der TLOs zugrunde liegen. 
Laut unserem Modell basieren sie auf der Präsenz einer gemeinsamen Zelle, der 
Perizyte. Diese Erkenntnis wird nicht nur das Verständis bezüglich der Enstehung von 
TLOs erweitern, sondern auch die Entwicklung von neuen therapeutischen Strategien 
im Falle von chronischen Entzündungen und Autoimmunerkrankungen vorantreiben.  
 Der zweite Teil meiner Dissertation befasst sich mit der Entwicklung von 
neuen transgenen Methoden, mit welchen wir verschiedene Fragen bezüglich FDCs 
zu beantworten suchen. Transgene Mäuse mit einer FDC-spezifischen Expression von 
Genen sollen verwendet werden, um das Mitwirken von FDCs in pathologischen 
Zuständen, wie zum Beispiel in Prionereplikation, der Entwicklung von autoimmunen 
Prozessen oder chronischen Entzündungen, zu erläutern. Ausserdem erhoffen wir, 
dass diese transgenen Tiere uns ermöglichen, die Abstammung der entwickelten FDC 
von der frühen FDC zu beweisen. Ich bin ich im Prozess der Herstellung von 
‚bacterial artificial chromosome’ (BAC) transgenen Tieren, welche den Mfge8 
Promoter zur Expression folgender Gene verwenden sollen:  
- Mfge8-Prnp, um das Prionenprotein auf FDCs zu beschränken  
- Mfge8-Cre und Mfge8-CreERT2 werden mir erlauben, FDCs konditionell zu 
entfernen, zu markieren und genetische Modifikationen auf FDCs zu beschränken 
- Mfge8-tdTomato, soll das Markieren und die Isolation von Zellen, die aktive Mfge8 
produzieren, erlauben  
- Mfge8-LT um zu eruieren, ob FDCs in autokriner und parakriner Interaktion zur 
Bildung von SLOs und TLOs fähig sind.  
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ABBREVIATIONS 
AID  activation-induced cytidine deaminase 
AIDS  acquired immune deficiency syndrome 
ALZ  apical light zone 
ANA  anti-nuclear antibody 
AP  alkaline phosphatase 
APC  antigen-presenting cell 
BAC  bacterial artificial chromosome 
BALT  bronchial associated lymphoid tissue 
BCR  B-cell receptor 
BLC  B-lymphocyte chemoattractant 
BM  bone marrow 
BSA  bovine serum albumin 
BSE  bovine spongiform encephalopathy 
CD  cluster of differentiation 
cDNA  complementary DNA 
CJD  Creutzfeldt-Jakob disease 
CNS  central nervous system 
CWD  chronic wasting disease 
CXCL  chemokine (C-X-C motif) ligand 
CXCR  chemokine (C-X-C motif) receptor 
ChloR  chloramphenicol resistance gene 
DC  dendritic cell 
DIG  digoxygenin 
dsDNA double-strand DNA 
DZ  dark zone 
ER  estrogen receptor 
Fc  Fc (fragment crystallizable) part of the constant domain of the antibody 
FcR  Fc (fragment crystallizable) receptor 
FcR  Fc gamma receptor 
FDC  follicular dendritic cell 
FFI  fatal familial insomnia 
FRC  fibroblast reticular cell 
FSC  follicular stromal cell 
GALT  gut associated lymphoid tissue 
GC  germinal center 
c  common cytokine receptor gamma chain 
GFAP  glial fibrillary acidic protein 
GSS  Gerstmann-Sträussler-Scheinker syndrome 
HE  hematoxylin and eosin 
HEV  high endothelial venules 
HIV  human immunodeficiency virus 
HRP  horseradish peroxidase  
i.p.  intraperitoneal 
i.v.  intravenous 
IC  immune complex 
ICAM-1 intercellular adhesion molecule 1 
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IF  immunofluorescence 
IFN  interferon 
Ig  immunoglobulin 
IHC  immunohistochemistry 
IL  interleukin 
ISH  in situ hybridization 
KO  knock out 
LEC  lymphatic endothelial cells 
LN  lymph node 
LPS  lipopolysaccharide 
LT  lymphotoxin 
LT  lymphotoxin alpha beta heterotrimer 
LTR  Lymphotoxin  receptor 
LTi  lymphoid tissue inducer cell 
LZ  light zone 
MAdCAM mucosal addressin cell adhesion molecule 
Mfge8  Milk fat globule-EGF factor 8 protein 
MS  marginal sinus 
MSC  mesenchymal stem cell 
MZ  marginal zone 
NK  natural killer cell 
NeoR  neomycin resistance gene 
OVA  ovalbumin 
PALS  periarteriolar lymphoid sheath 
PBS  phosphate buffered saline 
PK  proteinase K 
pGK  Phosphoglucokinase 
PP  Peyer´s patch 
PrPC  cellular isoform of the prion protein 
PrPSc  pathological isoform of the prion protein 
PS  phosphatidylserine 
qPCR  quantitative PCR 
ROR Retinoid-related orphan receptor gamma 
RT  reverse transcriptase 
SD  standard deviation 
SLE  systemic lupus erythematosus 
TBM  tingible body macrophage 
TBS  tris buffered saline 
TCR  T-cell receptor 
TD  T-cell dependent 
TetR  Tetracycline resistance gene 
TNF  tumor necrosis factor 
TSE  transmissible spongiform encephalopathy 
VCAM-1 vascular cell adhesion molecule 1 
WT  wild type 
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INTRODUCTION 
 
 
THE IMMUNE SYSTEM 
Overview of the immune system 
As defence against microbial and viral invaders, multicellular organisms have 
developed a complex array of defensive devices, called the immune system. Without 
such effective means of protection, any living thing would soon succumb to diseases 
caused by foreign organisms or substances. The challenge of immunity is to 
discriminate foreign and altered self from non-dangerous self and to respond after 
recognition of a danger signal such as a pathogen with the appropriate measures 
(Matzinger 2002).  
Plants and invertebrate animals, such as the Drosophila, have mainly 
developed innate responses. Foreign is recognized by pattern recognition receptors 
and defeated by the release of protective peptides and enzymes, which have antifungal 
or antibiotically properties (Zasloff 2002). The vertebrate immunity not only bases on 
innate, but also adaptive immune responses (Litman et al. 2005). In contrast to innate 
reactions, adaptive rebounds involve specific recognition of the invader, and the 
development of immunologic memory, which allows accelerated recognition and 
eradication of the same pathogen during a repeat exposure. The adaptive immune 
responses are carried out by lymphocytes and is divided into the humoral, or B 
lymphocyte mediated, and the cell-mediated, or T lymphocyte driven response. For 
proper responses to environmental dangers, the adaptive immune response needs to be 
well regulated. If the reaction is too low, we will not be efficiently protected against 
foreign assailants, while overreactivity of the adaptive immune response in turn may 
result in the attack of self. 5-7% of the human population are affected by autoreactive 
immune diseases. 
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Organs and cells of the vertebrate immune system 
In adult humans, all cells needed for innate and adaptive responses are generated from 
the same hematopoietic stem cell (HSC), residing in the bone marrow. HSCs are 
pluripotent and give rise to two different stem cells, the common myeloid progenitor 
(CMP) and the common lymphoid progenitor (CLP) (Reya et al. 2001). CMPs can 
generate macrophages, granulocytes, but also non-immune cells such as erythrocytes 
and platelets. CLPs are the progenitor cells of B and T lymphocytes, the main actors 
of the adaptive immune response, as well as of natural killer (NK) cells and dendritic 
cells (DC). 
Primary lymphoid organs  
Primary lymphoid organs are the sites where B and T lymphocytes mature. Here, they 
develop from their respective precursor and acquire their functional receptors, which 
ascertain the antigenic specificity later needed during the immune response. The 
broad repertoire of these receptors (for a multitude of antigens) is mainly based on 
recombinase activating gene (RAG) rearrangements of the multigenes coding for B or 
T cell receptor (Litman et al. 2005). 
B cells mature in the bone marrow (BM) in the presence of bone marrow 
stromal cells (BMSC). BMSC support the development of B cell precursors by direct 
interaction, but also by supplying them with secreted cytokines, such as interleukin 7 
(IL-7). The earliest cell in the B cell lineage is the pro B cell. It expresses the B cell 
marker B220, as well as the Ig/Igheterodimers. Upon contact of the pro B cell with 
the BMSC, differentiation into pre B cell is induced. In contrast to the pro B cell, the 
pre B cell has undergone VDJ gene rearrangement of the immunoglobulin heavy 
chain, and in conjunction with surrogate light chains and the Ig/Igheterodimer, 
forms the pre-B cell receptor. Furthermore, pre B cells upregulate IL-7 receptor (IL-
7R), allowing it to react to stromal IL-7. Further rearrangement of the light chain 
generates the mature B cell receptor (BCR), consisting of membrane bound 
immunoglobulin (mIg), in form of IgM and IgD, and the signaling transducing 
Ig/Ig heterodimers. Before mature B cells leave the BM to meet antigen, they 
undergo negative selection, a process which leads to the elimination of autoreactive B 
cells (Hardy and Hayakawa 2001).  
                                                                                INTRODUCTION 
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T cells develop from the CLPs in the thymus, where RAG rearrangements of 
the T cell receptor (TCR) multigene result in the formation of the mature TCR/CD3 
(cluster of differentiation 3) complex. Mature T cells detect antigen presented via the 
major histocompatibility complex (MHC). Therefore, immature T cells in the thymus 
undergo a round of positive selection, where they are instructed by thymic epithelial 
cells to recognize MHC molecules. Thymocytes unable to do so do not receive 
essential survival signals resulting in death by apoptosis. Immature T cells 
furthermore pass a negative selection process, where self reactive T cells are ablated. 
                                                                                INTRODUCTION 
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Fig. 1 Organization of the lymph node
LN is structurally divided into 3 distinct regions: cortex, paracortex and 
medulla (small figure). The cortex contains primary and secondary B cell
follicles containing germinal centers. The paracortex is rich in T helper cells
and interdigitating DCs. In the medulla plasma cells are present and lymph 
fluid is collected. Lymph fluid is transported to the LN via afferent
lymphatic vessels and leaves the LN via the efferent lymphatic vessels.
Lymphocytes migrate from the blood into the LNs emerging from
postcapillary venules. Adapted from Kuby immunology fifth edition 2002 
Secondary lymphoid organs  
In SLOs, mature B 
and T cells meet the 
antigen. SLOs are 
well structured 
organs, containing 
lymphocytes, 
phagocytes, antigen 
presenting cells 
(APCs) and stromal 
cells. The purpose 
of SLOs is to 
efficiently trap and 
present antigen in 
order to mount a 
quick and efficient 
immune response. 
Lymph nodes (LNs), 
spleen, mucosal 
associated lymphoid 
tissues (MALT) and 
gut associated lymphoid organs (GALT), including the Peyer’s Patches (PP), are 
SLOs. LNs and spleen are highly organized, encapsulated SLOs. While the spleen is 
specialized for immune responses to blood borne, thus systemic antigen, LNs collect 
antigen and antigen-experienced DCs from local tissues transported by lymph fluid 
within lymphatic vessels (Fig.1). Mammals carry a multitude of LNs present in head 
and neck regions, within the thorax, abdomen and limbs. The lymph from afferent 
vessels is collected in the subcapsular sinus, where a network of trabecula drains the 
LN’s cortex and paracortex, until the lymph is recollected in medullary sinuses and 
leaves the LN via the efferent lymphatic vessel. Lymphocytes enter the LN via high 
endothelial venules (HEVs), specialized postcapillary venules, which allow the 
transmigration of lymphocytes into and out of the organ. Upon antigen exposure of 
the LN, antigen-specific naïve B cells become activated and migrate into primary 
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Fig. 2 Organization of the spleen 
The spleen is an encapsulated organ, which lies within the peritoneum. The 
spleen is supplied with blood by the splenic artery, and blood leaves the 
organ via the splenic vein. The spleen is anatomically divided into the red 
pulp (RP) containing macrophages and erythrocytes and the white pulp 
(WP). The WP area surrounds the arterioles, and is subclassified into T cell 
rich, neighbouring the vessels, and a more distal B cell (follicular) area, 
structured in B cell follicles. At the border between WP and RP lies the MZ, 
consisting of specialized B cells and macrophages. 
Adapted from Kuby immunology fifth edition 2002 
follicles, where they start to proliferate. Primary follicles further develop into 
secondary lymphoid follicles containing GCs. During the GC reaction antigen-
activated B cells undergo affinity maturation of the BCR and class-switching.  
The spleen is an encapsulated organ, which lies within the peritoneal cavity. In 
contrast to LNs, the spleen is not supplied by lymph, but filters blood-borne antigen 
carried into the organ by the splenic artery. Hence, the spleen raises immune 
responses to systemic infections. It is compartmentalized into two functionally distinct 
areas, the red pulp (RP) and the white pulp (WP) (Fig.2). The RP’s main function is 
the removal of 
old and 
defective red 
blood cells. It 
consists of a 
network of 
sinusoids, 
vessels with a 
discontinuous 
endothelium, 
which allow the 
selection of old, 
less flexible 
erythrocytes, 
and contains a 
multitude of 
macrophages, 
removing the damaged erythrocytes. The WP is arranged around the splenic artery 
and arterioles. The innermost layer, the periarteriolar sheath (PALS), is rich in T cells, 
the B cell area is adjacent to the T cell zone and is structured in primary and 
secondary B cell follicles. The marginal zone (MZ) borders the RP area and contains 
specialized MZ B cells and macrophages. Blood-borne antigen reaches the spleen via 
the splenic artery, which further branches out into smaller arterioles and empties into 
the MZ. In the MZ antigen-antibody complexes (immune complexes) are trapped, and 
the early T cell independent (TI) immune response mediated by MZ B cells is induced 
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(Zandvoort and Timens 2002). From the MZ ICs are transported into the follicle and 
transferred onto specialized stromal cells, the FDCs, which ensure an efficient GC 
generation (Ferguson et al. 2004; Cinamon et al. 2008). In MALT and GALT, antigen 
is not delivered by means of vessels. In the intestine for example, antigen is 
transported from the lumen of the digestive tract through the mucosa by specialized M 
cells to the underlying lamina propria, which contains the immune cells (Neutra et al. 
2001). 
Tertiary lymphoid organs  
During persistent inflammations, either induced by a chronic exposure to a pathogen, 
tumor cells or during autoimmune reactions, structured lymphocytic infiltrates in non-
lymphoid organs can develop, which are termed TLOs (Aloisi and Pujol-Borrell 
2006). In contrast to SLOs, TLOs are neither encapsulated, nor supplied by a 
specialized vascular system. Similarly to SLOs, however, is the segregation into B 
and T cell specific zones, and the eventual emergence of B cell follicles containing 
GCs. A variety of target tissues of chronic inflammations are reported in humans, 
such as lung, liver, thyroid gland, central nervous system, gut, stomach, joints, 
arteries. Autoimmune diseases with reported TLO development are rheumatoid 
arthritis, multiple sclerosis, Hashimoto’s thyroiditis, and primary biliary cyrrhosis. 
Other chronic inflammatory diseases are Crohn’s disease and arteriosclerosis, TLOs 
associated with cancer occur in ductal breast carcinoma, while TLOs can also be 
induced by infection such as hepatitis C virus (Aloisi and Pujol-Borrell 2006). 
Generation of the B cell response  
Antigen naïve, mature B cells down regulate receptors for adhesion molecules 
expressed by BMSC, resolve the contact and leave the bone marrow. Via the blood 
stream they home to SLOs and TLOs, the places where they encounter antigen. 
Antigen binding on the mIg, results in the triggering of a signaling cascade which in 
turn leads to proliferation and differentiation of the mature B cells into antibody 
secreting plasma cells and memory B cells.  
In the spleen we discriminate two kinds of mature B cells, the follicular, which 
constitutes the main population, and the MZ B cells (5% of the total population). The 
first B cells to react to antigen and differentiate into antibody secreting plasma cells 
are the MZ B cells, lining the marginal sinus. Their threshold to become activated is 
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much lower than for follicular B cells, and induction is usually TI. TI antigens 
frequently stimulate B cells regardless of their antigenic-specificity. For example 
bacterial cell-wall polysaccharides, such as lipopolysaccharide (LPS), can act as TI 
antigen. TI responses are usually less pronounced than T cell dependent (TD) 
responses, and do not result in the generation of memory or seldom in class switching. 
In TD reactions the stimulation of the antigen-specific B cells is mediated by direct 
interaction with a cognate TH cell, a T cell responsive to the same antigen, as well as 
the presence of TH cytokines. The immediate reaction to a pathogen by B 
lymphocytes is the generation of short lived plasma cells, which secrete low affinity 
antibodies as a first defensive mechanism.  
The initial interaction of the B cell with the TH cell occurs extrafollicularly in 
the T cell zone (Gray 1988). In a second step some of the antigen-experienced B cells 
migrate into B cell follicles and get involved in the GC reaction, where B cells 
producing higher affinity antibodies with switched Ig class are generated (Fig. 3) 
(Kuppers 2003). At the beginning of the GC reaction, B cells, termed centroblasts, 
reside in the dark zone (DZ) of the secondary follicle. They undergo several rounds of 
clonal expansion, during which somatic hypermutation mainly within the variable 
region of the Ig happens, which is mediated by the activation induced cytidine 
deaminase (AID). AID recognizes cytosine bases in the Ig DNA and converts it into 
uracil. Mismatch repair removes uracil from the DNA and error prone polymerases 
replace the missing DNA pairs, which results in the generation of mutations. 
Centroblasts expressing very little membrane-bound Ig, exit from proliferation and 
start expressing surface-bound Ig. These so-called centrocytes migrate to the light 
zone (LZ) of the germinal center, where FDC and TH cells are located. During a 
process termed affinity maturation, selection of centrocytes expressing high affinity 
antibodies for antigen presented by FDCs as ICs, will be supplied with appropriate 
survival signals. At the same time centrocytes need to receive signals from cognate 
follicular TH cells. Signals so far identified to be important are the interaction of TH 
cells CD40L with its receptor CD40 expressed on the B cell (Guzman-Rojas et al. 
2002). Low affinity B cells undergo apoptosis, start displaying eat-me signals on their 
surface, leading to their removal by TBMs. One of these eat-me signals is the 
exposure of phosphatidylserine (PS), which is usually restricted to the inner leaflet of 
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Fig. 3 The germinal center 
The GC is divided into three main compartments: the mantle zone, the light zone and the dark zone. 
The DZ contains proliferating centroblasts, undergoing somatic hypermutation of the Ig genes. 
Centroblast stop dividing and differentiate into LZ centrocytes, expressing surface bound Igs. 
Centrocytes, with improved affinity for the antigen, are supplied with survival signals from TH cells 
and FDCs. Cells with lower affinity do not receive essential signals and undergo apoptosis. GC B 
cells, positively selected for antigen, undergo class switching. Cytokines present decide the type of Ig 
to be used. B cells then undergo final differentiation into antibody secreting, short lived plasma cells 
or memory B cells. Adapted from Nature Reviews Immunology 2003 (Kuppers 2003) 
 
the plasma membrane (Fadok et al. 1992; Koopman et al. 1994; Blankenberg et al. 
1998). 
Cytokines secreted by the cell determine the type of class switch that occurs 
after selection. While IL-1 promotes the generation of IgG1 and IgE, the presence of 
IL-4 induces a switch to IgE, IL-5 to IgA (Stavnezer et al. 2008). Before the 
positively selected GC B cells differentiate into plasma cells or memory B cells and 
leave the GC, they undergo several rounds of proliferation. Plasma cells, which are 
rather short lived cells, secrete high amounts of soluble Ig. Membrane bound and 
soluble Igs are splice variants from the very same RNA. Memory B cells on the 
contrary, are long lived B cells, giving rise to effector B cells very quickly after a 
secondary antigen exposure, without the need of a further GC reaction (Liu et al. 
1991). Different cytokines and transcription factors were associated with the fate 
decision plasma B cell or memory B cell (Liu and Banchereau 1997), OX40, IL-3, -6, 
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Fig. 4 Differences between FSCs and FDCs in primary and secondary follicles 
In primary follicles FSCs and FDCs are present. Though FSCs express some markers shared with 
FDCs, B3P3 and CXCL13, they do not capture ICs. Primary follicle FDCs stain for FDC-M1 and 
FDC-M2, PrP, FcRIIb, CD21/35, ICAM-1, VCAM-1. After antigen exposure, GCs are formed, 
leading to further differentiation of FDCs. LZ FDC express in addition MAdCAM and CD23 and 
have characteristic filiform dendrites, which ensheath the GC B cells. DZ FDCs lack the expression of 
FcRIIb, PrP, CXCL13, and MAdCAM, but express SDF-1 and fibrinogen. Adapted from Semin 
Immunology 2008 Cyster 
-10 favoring plasma cell development, while CD40L and IL-4 induce differentiation 
into memory B cells.  
FOLLICULAR DENDRITIC CELLS 
Characterization of Follicular Dendritic Cells 
Stromal cells constitute a major part of the lymphoid organs. In SLOs specialized 
reticular cells, or follicular stromal cells (FSCs), generate a network of cells, 
ensheathing the hematopoietic cells with their collagenous fibers and supporting the 
architecture of these organs by the secretion of extracellular matrix molecules. 
Analysis by electron microscopy revealed ultrastructural differences between the 
fibroblast reticular cells, and more dendritic shaped cells, termed dendritic reticular 
cells, which reside within GC of B cell follicles (Mitchell and Abbot 1965; 
Heusermann et al. 1980; Yoshida and Takaya 1989; Yoshida et al. 1993). One major 
reported feature of these dendritic cells, was the long-term retention of ICs, which was 
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dependent on the presence of complement and the Fc-part of antibodies (Papamichail 
et al. 1975; Klaus and Humphrey 1977; Chen et al. 1978). Subsequent studies 
revealed that the receptors for complement, the complement receptors, CR1 (= CD35) 
and CR2 (= CD21) and the Fc receptor, Fc gamma RIIb (FcRIIb), were needed for 
the IC-trapping (Yoshida et al. 1993; Imal and Yamakawa 1996; Qin et al. 2000). 
Later these dendritic reticular cells were termed FDCs to discriminate them from the 
other reticular cells (Tew et al. 1982). However, transitional forms between fibroblast 
reticulum cells (FRCs) and FDCs were observed during GC reactions, providing 
evidence of their fibroblast-like, mesenchymal phenotype (Kamperdijk et al. 1978; 
Yoshida and Takaya 1989; Yoshida et al. 1993). 
FDCs so far are determined by their ability to bind ICs. They are present in 
primary lymphoid follicles, but especially prominent in secondary lymphoid follicles. 
Here, they reside in the LZ as well as DZ of the GC, and adapt to their local functions 
with slightly distinct appearance and molecular characteristics (Fig. 4). Especially 
FDCs in GC LZ have very elaborate filiform processes forming a dense network, 
entangling the centrocytes. CD21 and CD35 are present on both primary and 
secondary FDCs. Primary follicles FDCs express BP3, FcRIIb (CD32), vascular cell 
adhesion molecule 1 (VCAM-1), intercellular adhesion molecule 1 (ICAM-1), FDC-
M1 (= Mfge8), FDC-M2 (= complement C4), CXCL13 (BLC), and the prion protein 
(PrP). After immunization and GC development, FDCs upregulate the listed markers 
and in addition start expressing mucosal addressing cell adhesion molecule 
(MAdCAM), CD23 (=FcRII), which is only present in LNs, but not spleen. DZ 
FDCs are BP3+ and express CD21/35, SDF-1 and fibrinogen. They show little IC-
trapping, are slightly positive for FDC-M1, ICAM-1 and VCAM-1, but are negative 
for FDC-M2 or CXCL13, CD23 and FcRIIb. 
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Function of Follicular Dendritic Cells 
Secretion of chemokines/attraction of lymphocytes 
One of the hallmarks of FDCs is the secretion of chemokines, which result in the 
recruitment of lymphocytes to the follicles of the SLOs and TLOs. One of these 
factors is the B lymphocyte chemoattractant (BLC, CXCL13). It is produced and 
secreted by FDCs as well as other sinus lining FSCs, and binds to B cells’ CXCR5, 
thus leading to their migration into the follicles (Gunn et al. 1998). BLC is made by 
FDCs of the primary lymphoid follicle and LZ FDCs. DZ FDCs do not express it, but 
produce another chemokine, SDF-1 (CXCL12), which signals via CXCR4. SDF-1 
determines the development of the GCs and is needed for the segregation into LZ and 
DZ. Consistent with the notion that production of BLC by FDCs strongly regulates B 
cell follicle and GC organization is the phenotype of mice deficient for BLC or its 
receptor CXCR5. These mice lack most of the LNs as well as the PPs and have 
disorganized GC with B-cell accumulation around the central arteriole (Ansel et al. 
2000). 
Production of adhesion molecules for lymphocytes 
For the proper migration of lymphocytes into the organs not only chemokines, but 
also adhesion molecules are needed. FDCs display several adhesion molecules, which 
are essential for the close FDC/B cell interaction. When FDCs are isolated and co-
cultured with B cells they form clusters, suggesting the presence of adhesion 
molecules (Tsunoda et al. 1992). Several adhesion molecules have so far been 
identified to be expressed by FDCs, including ICAM-1, VCAM-1, MAdCAM. 
ICAM-1 and VCAM-1 ligands are from the integrin family, namely LFA-1 
(lymphocyte function associated antigen 1, a heterodimer of integrin L and 2) as a 
receptor for ICAM-1 and the VCAM-1 receptor VLA-4 (very late antigen 4; intergrin 
41). LFA-1 and VLA-4 are both present on B cells. Indeed, when these ligands or 
receptors are blocked by antibodies, in vitro cluster formation of FDC and B cells is 
severely reduced (Koopman et al. 1991).Also FSCs in the MS express ICAM-1 and 
VCAM-1, which is needed for the localizing MZ B cells. 
Display of immune complexes and affinity maturation of B cell  
                                                                                INTRODUCTION 
 _____________________________________________________________________ 
                                                                                                                             23
 
One of the major features of FDCs is the trapping of ICs on their surface via the 
expression of Fc (fragment crystallizable) receptors, FcRII and FcRIIb, and 
complement receptors, CD21 and CD35 (Tew et al. 1982). ICs can either be 
composed of antigen-antibody, antigen-complement or antigen-antibody-complement. 
In LNs ICs are first captured by subcapsular sinus macrophages, non-cognate B cells 
transport the ICs into the GCs and transfer them onto FDCs, where they are retained 
over long periods (Phan et al. 2009). FDCs present native antigen to naïve B cells, GC 
B cells and memory B cells. In vitro it was shown that the presence of ICs is highly 
stimulatory to B cells and results in the upregulation of AID in the B cell, which in 
turn leads to somatic hypermutation of the Igs and class-switching. In vitro culture of 
GC B cells also showed that in the absence of survival factors this cell type undergoes 
cell death within short term. However, the addition of FDCs and T cells to GC B cell 
cultures lead to an increase in their survival (Burton et al. 1993). Supply with B cell 
specific antigen further increased their viability (Kosco et al. 1992). The exact 
signaling mechanisms of GC survival are not completely understood. It is believed 
that GC B cells are death prone by high expression of Fas receptor (FasR) as well as 
its ligand FasL. Unknown signals supplied by T cells and FDCs in turn lead to the 
upregulation of Fas-associated death domain-like IL-1-converting enzyme-like 
inhibitory protein (cFLIP(L), which inhibits FasR-induced caspase activation (van 
Eijk et al. 2001). It is so far believed that in the GC B cells compete for the antigen 
presented by FDCs, and only B cells binding with high affinity obtain survival 
signals, while the remaining die and are removed by local macrophages, the tingible 
body macrophages (TBMs). Although, mice lacking FDCs or complement receptors, 
can undergo a GC reaction and class switching, this process is strongly hampered and 
needs the presence of high amounts of antigen as well as adjuvants (Kosco-Vilbois 
2003). 
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Fig. 5 Model of the removal apoptotic B cells by TBMs 
FDCs supply high affinity B cells with so far unknown survival 
signals which inhibit the proapoptotic state. Apoptotic B cells 
are covered with Mfge8, secreted by the FDC, binding to the 
exposed PS. The RGD motif of Mfge8 leads to the recognition 
by TBMs integrin receptors and subsequent engulfment.  
Removal of apoptotic GC B cells 
90% of the GC B cells do not 
survive the selection 
procedure and undergo 
apoptosis. During this process 
they display so-called ‘eat-me 
signals’, including 
phosphatidylserine (PS), on 
their surface and are rapidly 
removed by TBMs 
(Flemming 1885; Smith et al. 
1991; Fadok et al. 1992; 
Koopman et al. 1994; 
Blankenberg et al. 1998). 
Under normal circumstances 
PS is kept on the inner leaflet 
to the plasma membrane by 
the help of flippase, during 
cell death the phospholipids 
asymmetry between inner 
and outer leaflet can no 
longer be maintained and PS 
becomes exposed on the plasma membrane outer surface as well. FDCs play a crucial 
role in the B cell removal process by secretion of milk fat globule epidermal growth 
factor 8 (Mfge8 = lactadherin), a PS-binding protein required for the engulfment of 
apoptotic cells by macrophages (Fig. 5) (Hanayama et al. 2002; Hanayama et al. 
2004; Kranich et al. 2008). Mfge8 has a recognition site for PS, but also contains the 
integrin binding RGD (arginine-glycine-aspartate)-motif, which is recognized by 
integrin v3 expressed on TBMs, linking the apoptotic cell to the macrophage and 
ensuring its removal. Impairment of Mfge8-dependent removal of apoptotic GC cells 
has been associated with lupus-like autoimmunity (Hanayama et al. 2004). 
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Follicular dendritic cells during pathological conditions 
Tumours with immunohistochemical characteristics of FDCs, e.g. expression of the 
FDC markers CD21, CD23, CD35, Clusterin do exist. FDC tumours (FDCT) are 
usually found in lymphoid tissues, such as LNs, tonsils and spleen, but can also be 
present at other sites such as gastrointestinal tract, and more recently described in lung 
(Denning et al. 2009). 
FDCs in chronic inflammatory conditions and autoimmunity 
As a constitutive part of primary and secondary follicles, FDCs can also develop 
during chronic inflammatory diseases to generate TLOs and stabilize their persistence. 
Chronic inflammations occur either during a prolonged infection with impaired 
clearing, as a response to a tumor or as a consequence of an autoimmune disease. 
Several autoimmune diseases are associated with the development of ectopic TLOs. 
In the thyroid gland this is Hashimoto’s thyroiditis, and Grave’s disease, in the joints 
rheumatoid arthritis, multiple sclerosis affecting the CNS, and cryptogenic fibrosing 
alveolitis in the lung. In the GCs of these TLOs, organ-specific and disease-associated 
autoantibodies are generated, by the help of the local FDCs. Infections can lead to de 
novo formation of TLOs as well, as it is the case in chronic hepatitis C, Helicobacter 
pylori induced gastritis (Aloisi and Pujol-Borrell 2006). Chronic inflammations are 
also associated with the development of lymphomas, which develop most probably as 
a consequence of continuous B cell proliferation (Hjelmstrom 2001). 
Another autoimmune disease with possible FDC misfunction is systemic lupus 
erythematosus (SLE). Unlike organ-specific autoimmune diseases SLE affects the 
organism systemically. During this disease antibodies against a plethora of tissue 
antigens, including DNA and nuclear proteins form antigen-antibody complexes. 
These complexes can on one hand destroy the targeted cells, e.g. neutrophils, on the 
other hand lead to the activation of the complement system, but also become 
deposited in certain tissues, where they lead to local damage. The synovial tissue of 
the joint, the pleura of the lungs, the skin as well as the kidney’s glomerula 
(glomerulonephritis) are classical places of tissue destruction in SLE. The occurrence 
of SLE is linked to defects in the removal of apoptotic cells by macrophages, 
especially the reduced clearance of GC B cells by TBMs has been reported (Baumann 
et al. 2002). Non-phagocytosed apoptotic cells undergo secondary necrosis, which 
will result in the generation of self-reactive antibodies against nuclear antigens of 
                                                                                INTRODUCTION 
 _____________________________________________________________________ 
                                                                                                                             26
 
Fig. 6 Colocalization of FDCs with PrPSc deposits 
Consecutive splenic cryosections stained with hematoxilin-eosin (HE) (left), or with the FDC marker 
FDC-M1 (middle) and a histoblot to detect PK resistant PrPSc (right). Adapted from J Neuroim 
(Heikenwalder 2007) 
these cell remnants. Supporting this theory are following observations: The absence of 
two factors, C1q and Mfge8, linking the apoptotic cell to the macrophage and thus 
enabling its removal, are associated with the development of SLE-like phenotype in 
mice (Walport et al. 1998; Gaipl et al. 2004; Hanayama et al. 2004; Gaipl et al. 2005). 
Recently, a genetic polymorphism in the human MFGE8 gene was reported in patients 
with SLE (Hu et al. 2009). Surprisingly, the group of Nagata found increased levels of 
serum Mfge8 in patients with SLE (Yamaguchi et al. 2008).This could be explained 
by a dose dependent function of Mfge8. While bantam and local amounts leads to the 
linkage of the apoptotic cell to the macrophage, excessive Mfge8 will bind to the PS 
on the dying cell’s surface or cover the integrin binding sites without acting as a 
bridging molecule. Interestingly, Mfge8 in the lymphoid follicles is produced by 
FDCs and mice lacking mature FDCs have impaired removal of apoptotic B cells and 
increased levels of autoantibodies (Chin et al. 2003; Kranich et al. 2008). This 
suggests a beneficial role of FDCs in the prevention of self-reactive immune diseases, 
by controlling the appropriate removal of B cells during the GC reaction via Mfge8. 
Infectious diseases with FDC involvement 
FDCs can also act as a ‘Trojan horse’ during certain infectious diseases. Upon 
infection with human immune deficiency virus (HIV) and seeding of the viral 
particles to lymphoid organs, FDCs represent the major reservoir of HIV, trapping 
them on their surface (Racz 1988; Pantaleo et al. 1993; Cavert et al. 1997). The 
particles bound as ICs not only help initiating and maintaining the HIV-specific 
immune response, but can also act as a constant source of infection for nearby CD4+ 
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T-cells, the main target of HIV (Schrager and Fauci 1995). Surprisingly, despite being 
bound as ICs and hence covered with antibodies, virions are still infectious for (Heath 
et al. 1995). Hand in hand with the very efficient accumulation of retroviral virions, 
FDCs rapidly lose their ability to efficiently trap and retain antigens, apart from viral 
ones, as shown by Masuda et al. using a murine model of HIV (Masuda et al. 1993; 
Masuda et al. 1995). During further progression of disease, the lymphatic 
microenvironment, including the FDC networks, is eventually destroyed, a 
phenomenon that also occurs during other viral or bacterial infections (Pantaleo et al. 
1993; Smelt et al. 1997). Surprisingly, FDCs were also shown to be involved in a 
class of diseases affecting the CNS, the transmissible spongiform encephalopathies 
(TSEs). TSEs are fatal neurodegenerative disorders, which can occur in many 
different mammalian species. TSEs occurring in humans are Kuru, Gerstmann-
Sträussler-Scheinkler syndrome (GSS), Creutzfeldt-Jakobs disease (CJD), new variant 
CJD, and fatal familiar insomnia (FFI), in cattle as bovine spongiform encephalopathy 
(BSE) or ‘mad cow disease’, scrapie in sheep and goat as well as chronic wasting 
disease (CWD) in elk and deer. TSE’s common feature is the deposition of large 
extracellular amyloid-like aggregates, accompanied by neuronal loss and spongiform 
changes in the brain, gliosis (Prusiner et al. 1983; Weissmann 2004). TSEs are caused 
by an infectious agent called the prion (Prusiner 1982). In a classical infectious 
disease the causative agent is assembled from proteins, lipids and nucleic acids, no 
matter whether it is a parasite, a bacterium, a fungus or a virus. Yet, the infectious 
agent of TSEs, is only a protein. The prion, or PrPSc (PrPScrapie), is an abnormally 
folded, proteinase K (PK) resistant, β-sheet rich form of the endogenous cellular prion 
protein, PrPC (Bolton et al. 1982; Prusiner 1991). That PrPSc is a misfolded version of 
the endogenous PrPC, was allegorized in mice deficient in PrPC – after challenge with 
else contagious prions, these mice remained healthy and did not suffer from 
neurodegenerative disorders (Büeler et al. 1993). FDCs not only express high levels 
of PrPC, but also promote the accumulation of PrPSc after infection (Kitamoto et al. 
1991; McBride et al. 1992; Jeffrey et al. 2000; Thielen et al. 2001; Heggebo et al. 
2002)(Fig. 6). A central role of FDCs in the neuroinvasion after peripheral exposure 
to prions was shown in mouse models lacking mature FDCs, where disease was either 
abrogated completely, or delayed (Mabbott et al. 2000; Mabbott et al. 2000; 
Montrasio et al. 2000; Mabbott et al. 2002; Prinz et al. 2002; Mabbott et al. 2003). 
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Many publications suggest that after accumulation and replication of prions in the 
peripheral lymphoid organs, the innervations of LNs and spleen by peripheral nerves 
represent the entry site of prions to the CNS (Fig. 7). While sympathectomy delayed 
the progression of prion diseases upon peripheral administration in mice, splenic 
hyperinnervation resulted in an acceleration of incubation time (Glatzel et al. 2001). 
Furthermore, mice with FDCs juxtaposed to the splenic nerves (Cxcr5-/-) show an 
increased velocity of prion neuroinvasion into the spinal cord (Prinz et al. 2003). The 
capture of prions by FDCs was shown to be dependent on the presence of complement 
and complement receptors. After peripheral prion infection mice lacking is CD21/35, 
or different complement components such as C1q, C3, or C4 had less prions 
accumulating in SLOs and were partially or fully protected against prion diseases 
(Klein et al. 2001; Mabbott et al. 2001).  
DEVELOPMENT OF FOLLICULAR DENDRITIC CELLS 
The induction of secondary lymphoid organs 
While TLOs are generated postnatally in the presence of antigen, the SLO anlagen 
form during embryonic development of vertebrates. This process requires the 
coordinated interplay of cell populations, migratory hematopoietic cells and local non-
hematopoietic stromal cells, and molecules including chemokines, adhesion 
molecules, and cytokines.  
Members of the tumor necrosis factor (TNF) family are major molecular 
switches needed for LN development. Especially LT signaling was shown to be a 
main driver of SLO development. The lymphotoxin complex (LT), consisting of 
one alpha and two beta subunits, interacts with the lymphotoxin  receptor (LTR). 
Mice lacking LT signaling, due to genetic ablation or treatment with a soluble decoy 
LTR, do not develop LNs, or PPs, and have a disturbed splenic microarchitecture 
(De Togni et al. 1994; Browning et al. 1995; Rennert et al. 1996; Futterer et al. 1998) 
Events at the cellular level are the following. At the future sites of LNs, lymph 
sacs bud off from venous vessels, and blood cells start to accumulate within. It was 
long believed that lymph sacs are essential for the initiation of lymphocyte clustering 
(Sabin 1902). Recently, it was shown that in the absence of lymphatic endothelial 
cells (LEC) and thus lymph sacs, LN anlagen are induced, however the progression of 
LN development is slowed down (Vondenhoff et al. 2009). Stromal organizer cells 
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(SOCs) are present at the future sites of LNs. They express the chemokine CXCL13, 
are positive for the adhesion molecules VCAM-1 and ICAM-1 and LTR (Honda et 
al. 2001). CXCL13 expression is usually triggered by activation of the LT pathway. 
Nevertheless, in the very early LN development, CXCL13 is independent from LT, 
and seems to be regulated by other mechanisms, such as nerve activation (van de 
Pavert et al. 2009). 
The first hematopoietic cells to arrive at the sites of future LNs, are the 
lymphoid tissue inducer cells (LTis). These cells are CD4 positive, but in contrast to T 
helper cells they do not express CD3, but LT, IL-7R, RORct (Retinoid-related 
orphan receptor gamma) (Cupedo et al. 2002). That LTis indeed are important for the 
initial induction of future LNs, was shown in mice deficient in RORc(t: here, 
dependent on the report LTis are absent and LNs do not form (Kurebayashi et al. 
2000; Sun et al. 2000; Eberl et al. 2004). LTis cluster at sites where SOCs are present 
(Fig. 8), attracted by CXCL13 and adhesion molecules (Aloisi and Pujol-Borrell 
2006; Vondenhoff et al. 2007). LTis then signal to the SOC via the expression of 
surface LT inducing a positive feedback loop. The SOCs further upregulate 
adhesion molecules, chemokines, and lymphangiogenic factors (Vondenhoff et al. 
2009). This results in the development of HEVs and the influx of naïve lymphocytes. 
Furthermore, separate T and B cell zones establish as a result of specific stromal 
Fig. 8 Lymph node development  
LTis arrive at future LN sites and interact with the local SOC, through the binding of LT to stromal 
LTR. Subsequent upregulation of chemokines, adhesion molecules, and lymphangiogenic factors, 
results in the formation of HEVs, which allow the further influx of LTis and of first B and T cells 
supplying the developing node with essential LT. Later during development, distinct B and T cell 
zones are established. Adapted from Nature Reviews Immunology (Aloisi and Pujol-Borrell 2006) 
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Fig. 8 Ligands and receptors of the TNF family 
TNFLT2 and LT3 are expressed by the B cell. 
TNFLT2 are membrane bound, LT3 is secreted. 
LT2 signals via the LTR and activated the NFb 
pathway. TNFand LT3 signal via TNFR1 and 
TNFR2. TNFR1 engagement results in activation of the 
NFb as well as the death pathway. Adapted from 
Annual Review of Immunology (Ware 2005) 
compartments, and FDCs undergo final maturation in the presence of B cell 
membrane bound LT. 
The differentiation of follicular dendritic cells 
FDCs have major functions in establishing the microarchitecture of SLOs and TLOs 
during steady state as well as during active adaptive immune response. They maintain 
tissue structure via secretion of chemokines and production of adhesion molecules. 
During the GC reaction they ensure affinity maturation of B cells displaying native 
antigen on their surface and supplying high affinity antibody bearing B cells with 
survival factors, while 
controlling the appropriate 
removal of dying cells and cell 
debris by TBMs secreting factors 
such as Mfge8 (Cyster et al. 
2000). Still, little is known about 
the origin of this cell type. Major 
investigations were undertaken 
to determine signaling 
mechanisms in FDC maturation 
and maintenance. The study of 
knock out mice revealed that 
FDCs allure follicular B cells via 
the secretion of CXCL13, and B 
cells in turn support the 
differentiation of FDCs. Mice 
lacking CXCL13 or its receptor 
CXCR5 have mislocalized FDCs 
and B cell zones, and more dramatic, mice devoid of B cells do not sustain presence 
of FDCs (Cerny et al. 1988; Forster et al. 1996; Ansel et al. 2000). Interestingly the 
majority of B cells express the CXCL13 receptor CXCR5, however, other molecular 
cues must exist, which specify the restricted migration of certain B cell 
subpopulations into the follicle (Forster et al. 1994; Forster et al. 1996)). The 
molecular signaling events needed for the generation of FDCs could be attributed to 
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Table 1 Genetic deficiencies in LT and TNF signaling pathways and correlated phenotypes 
Genetic deletions are indicated in the left row. – absent, + present, FDCs: +/- FDC like cells were 
reported in the marginal zone of the spleen. LNs: +/- approximately 75% of MLNs present. Adapted 
from Annual Reviews Immunology (Fu and Chaplin 1999; Ware 2005). 
LT and TNF highly expressed by B cells (Fig. 9) (Chaplin and Fu 1998; Ware 2005). 
While the LT2 signals through LTR, TNF and the soluble LT alpha homotrimer 
(LT3) interact with TNFR1 and TNFR2. Engagement of LTR induces both NFb 
(nuclear factor kappa B) pathways, the classical one, signaling via IKK complex 
leading to the nuclear translocation of the transcription factor RelA, as well as the 
non-canonical pathway via NIK-IKK and transfer of RelB into the nucleus. TNFR1 
stimulation activates the canonical NFb pathway as well as the death signaling 
cascade (Ware 2005). RelA induces the transcription of inflammatory genes. RelB on 
the contrary is needed for the expression of genes regulating development.  
Though mice devoid of TNFor TNFR1 maintain having LNs and PPs, they 
lack mature FDCs and show a disrupted splenic microarchitecture (Table 1). 
Segregated T and B cell areas are established, but they are mislocalized, with 
follicular B cells accumulating underneath the marginal sinus (MS) (Le Hir et al. 
1995; Le Hir et al. 1996; Pasparakis et al. 1996; Pasparakis et al. 2000). Mice with a 
deficiency in LTR signaling have a more dramatic block in SLO development. In 
mice without LT or LTR, none of the LNs and PPs can be observed, whereas Ltb-/- 
animals retain certain LNs. The splenic white pulp is severely disorganized, T and B 
cells are intermingled, and no FDCs are present (De Togni et al. 1994; Koni et al. 
1997; Futterer et al. 1998). The importance of LT and TNF not only in the formation 
of FDCs, but also in their maintenance, was allegorized in an experiment done by 
Mackay et al., where a soluble LTR-Ig decoy receptor was used to block 
endogenous signaling (Mackay and Browning 1998). This resulted in the 
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dedifferentiation of the mature FDCs within a matter of days. On the contrary, 
overexpression of LT in non-lymphoid organs such as the pancreas, kidney, skin or 
liver, leads to the generation of ectopic TLOs containing mature FDCs (Picarella et al. 
1992; Heikenwalder et al. 2005). 
 As discussed some signaling switches needed for FDC development and 
maintenance are understood. Hardly anything however is known about the founder 
cell giving rise to mature FDCs. The main efforts undertaken, so far, studied whether 
FDCs are derived from a hematopoietic or from a non-lymphoid, mesenchymal cell. 
Their mesenchymal origin is supported by BM reconstitution experiments in wild type 
(WT) mice after lethal irradiation. These experiments show that after a reconstitution 
period of a year all FDCs are derived from a stromal compartment of the host animal 
(Humphrey et al. 1984). Grafting experiments, where splenic slices were transplanted 
subcutaneously into mice, showed that after 6 months the donor tissue had been 
populated by hematopoietic cells from the host mouse, but all FDCs remained donor 
derived. These results further corroborated previous results, suggesting that FDCs are 
derived from a local, rather sessile, and non-hematopoietic cell (Imazeki et al. 1992). 
Another study by the group of Szakal questions the sessile and mesenchymal origin of 
FDCs (Kapasi et al. 1998). Here, neonatal mice with severe combined 
immunodeficient (SCID), reconstituted with BM or fetal liver cells from mouse and 
rat donors, developed in parts FDCs that were of donor origin. BM and blood are not 
only a source for hematopoietic cells, but do contain mesenchymal stem cells (MSC) 
(Campagnoli et al. 2001; Roufosse et al. 2004). These data suggest that under certain 
circumstances FDCs can be derived from a migratory cell derived from the BM, be it 
a hematopoietic or mesenchymal one. 
When postnatal development of FDCs in mouse spleens was studied using the 
anti-FDC-M1 antibody, cells expressing its antigen, Mfge8, were not detected before 
postnatal day 3 (Balogh et al. 2001; Kranich et al. 2008). These cells were appearing 
along peripheral parts of the emerging white pulp and were radiation resistant. The 
first occurrence of IC trapping cells was reported only later at the age of 2-3 weeks 
(Yoshida and Takaya 1991; Imazeki et al. 1994). The study of TNFR1 signaling 
deficient mice revealed cells with a dendritic appearance in the MZ, expressing C4 
(FDC-M2) as well as CD35. These observations, however, should be considered with 
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the notion that these mice have a dramatic increase in MZ B cells, cells which localize 
to the very same area of the lymphoid follicle and stain for C4 and CD35.  
Electron microscopic experiments had revealed ultrastructural differences 
between FDCs and other fibroblast reticular cells within the follicles (Mitchell and 
Abbot 1965; Heusermann et al. 1980; Yoshida and Takaya 1989; Yoshida et al. 
1993). After immunization with antigen and induction of GC reactions, transitional 
forms between the two cell types were observed, adding evidence for a mesenchymal, 
and fibroblast origin of FDCs (Kamperdijk et al. 1978; Yoshida and Takaya 1989; 
Yoshida et al. 1993).  
Even though there are many indications for a mesenchymal origin of FDCs, 
the true founder cell has remained as elusive as the question, whether FDCs are 
derived from a stromal cell, with a sessile or a migratory character. 
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OUTLINE OF THE STUDY 
It hat so far been technically challenging to follow FDC maturation for different 
reasons. First of all, FDCs share many markers with other cells. e.g. CD21/35 and 
FcRIIb are expressed by follicular B cells as well as MZ B cells. FDCs’ main 
characteristic is the trapping of ICs, a function which is established by the time when 
FDCs are mature. IC-capturing assays can therefore not be used to follow FDC 
precursor differentiation. Another useful marker for FDCs is FDC-M1, however it 
also detects TBMs, and the antigen detected by the anti-FDC-M1 antibody had been 
unknown. This lack of FDC-specific markers also made a transgenic approach to 
follow FDC progenitors by tracing impossible. 
 
Huber et al. performed a transcriptomic microarray analysis to identify FDC-specific 
genes. For this, the gene profile of isolated FDCs was compared to WT spleens, 
containing FDCs, and spleens from Ltbr-/- mice, which are devoid of FDCs. In 
addition RNA expression of mice depleted conditionally of FDCs by treatment with 
soluble LTR-Ig fusion protein was assessed (Huber et al. 2005). One of FDC-
associated marker identified by this screen was Mfge8. 
 
Using different approaches, we could show that FDC-M1 is identical to Mfge8 
(Kranich et al. 2008). Since Mfge8 is a secreted protein involved in the removal of 
apoptotic cells from GCs by TBMs, we hypothesized that Mfge8 positivity of TBMs 
could occur secondarily due to their phagocytic activity. Indeed, using different 
techniques including in situ hybridization (ISH) for Mfge8 mRNA, we could show, 
that all Mfge8 in SLOs was derived from stromal cells, mainly FDCs, and not 
macrophages. The other stromal cells producing Mfge8 were lining the marginal sinus 
and within the T cell area of the splenic follicle. 
 
Further analysis revealed that these cells expressed many other FDC markers, were 
insensitive to irradiation, but their maintenance was LTR-dependent. These results 
confirmed the close relationship of the cells to mature FDCs and were suggesting that 
they could be putative precursors.  
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Next, I assessed the presence of these possibly early stage FDCs in different mice 
lacking mature FDCs. I pinpointed down a role of TNFR1 and B cells in the final 
maturation of FDCs. The early development was mainly determined by LTR and the 
common cytokine receptor gamma chain, and lymphoid tissue inducers. These results 
provide new insights in molecular and cellular mechanisms in FDC development.  
 
In addition, I analyzed the expression of Mfge8 in kidney and liver, as examples for 
non-lymphoid organs, where FDCs can be induced ectopically. In the kidney, Mfge8 
was found in the glomerular structures, probably produced by mesangial cells. In WT 
livers, Mfge8 could be detected in oval cells, and expression was independent from 
LTR activation. Upon treatment of mice with LTR agonist, Mfge8 in oval cells as 
well as other cells of the liver was upregulated. 
 
I furthermore studied the development of FDCs using Mfge8 ISH in postnatal mice as 
well as in Rag2-/-c-/- mice. Rag2-/-c-/- spleens lacked follicular structures, and few 
Mfge8+ cells clustered perivascularly. In these mice FDC development was induced 
by reconstitution with WT BM. This revealed that FDCs form in a continuous process 
– first, appearing and expanding at perivascular sites, later, budding off into the future 
B cell follicles. The same ontogenetic processes could be recapitulated studying the 
postnatal development. These results suggests a continuous maturation of perivascular 
precursors, which I termed proFDCs, into so-called preFDCs of the MS and the 
follicles, undergoing terminal differentiation this leads into the generation of mature 
FDCs. Mutant mice that had been analyzed previously, therefore, reflect the blockade 
of FDC maturation at certain developmental stages. 
 
I then set out to determine the true founder cell. The perivascular appearance in the 
spleen suggested that FDCs might be derived from a perivascular stem cell. Pericytes 
are of mesenchymal origin and are reported to be stem cells for fibroblast, muscle, 
and fat tissue. Using a pericyte reporter mouse I determined that mature FDCs are 
derived from Pdgfrb-expressing cells, which probably reflect pericytes. 
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Furthermore, I developed tools to answer following FDC-related questions: 
- what is the contribution of early Mfge8 expressing cells in SLOs to the mature FDC 
pool? 
- which cells are the FDC precursors in non-lymphoid organs? 
- is there a direct involvement of FDCs in prion replication, autoimmunity and chronic 
inflammations, cancer? 
 
Therefore transgenic mice were generated to irreversibly label precursors of FDCs 
and facilitate the isolation of FDCs at different developmental step, as well as to gene 
target and conditionally ablate FDC populations. DNA constructs were made using 
bacterial artificial chromosome (BAC) technology, placing 5 different constructs 
under the control of the Mfge8 promoter. So far 4 constructs were injected into 
oocytes to generate transgenic mice.
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Fig. 1 Staining for FDC-M1 and RNA ISH for Mfge8 
Consecutive sections of a WT mouse spleen where either stained for FDC-M1 (Mfge8) and 
counterstained with haematoxylin or hybridized with a DIG-labelled AS probe for Mfge8 and stained 
with anti-DIG antibodies. Mature FDC networks as well as cell in the marginal sinus and the T cell 
zone express Mfge8 RNA. Scale bar 100m.  
Fig. 2 RNA ISH for Mfge8 and Blc 
Consecutive sections of a WT mouse spleen where hybridized with a DIG-labelled AS probe for 
Mfge8 (left), respectively Blc (middle) or stained with HE. Mature FDC networks (*) and cells lining 
the MS (arrows) are positive for both markers. Scale bar 100m.  
 
 
 
 
 
RESULTS 
 
 
THE DISCOVERY OF CELLS WITH RELATIONS TO FDCs 
MZ Mfge8+ cells express markers of FDCs  
Originally, I had performed in situ hybridization (ISH) for Mfge8 on WT splenic 
sections, to determine the cellular source of this secreted protein (Kranich et al. 2008). 
Comparing the protein staining by immunohistochemistry (IHC) with the pattern of 
Mfge8 RNA detected by ISH, I realized that RNA detection not only is more specific 
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than IHC for the protein, as TBM are not detected, but also far more sensitive. Cells 
in the area of MZ and within the T cell area would be readily determined by ISH 
(Fig.1). This suggested that these cells might be related to mature FDCs and even 
represent precursors (preFDCs) that had been suggested to exist in the MZ. To test 
this idea, I performed ISH for Blc RNA, a factor secreted by FDCs, and compared its 
expression pattern to the one of Mfge8 (Fig. 2). The staining intensity for Blc on 
mature FDCs as well as on preFDCs was weaker, nevertheless the pattern was very 
much alike the ISH for Mfge8. Furthermore, co-stainings of Mfge8 with other FDC 
markers, including BP3 and PrP, the adhesion molecules ICAM-1 and MAdCAM, the 
receptors essential for the IC capturing by FDCs CD21/35 and FcRIIb were 
performed (Fig.3, data not shown). ICAM-1 and MAdCAM were co-localizing well 
with mature FDCs as well as preFDCs (Fig. 3 A, B). Immunofluorescence for 
CD21/35 (Fig. 3 C), and FcRIIb (data not shown) determined that mainly mature 
FDCs express these markers, but also low expression by other cells, presumably 
follicular and MZ B cells, was detected. BP-3 showed co-localization with FDCs and 
Fig. 3 FDC markers present on MS preFDCs 
Splenic cyosections double stained with Mfge8 and ICAM-1 (A), MAdCAM (B), CD21/35 (C), or 
BP3 (D). MS preFDCs. show high expression of the FDC markers ICAM-1, and MAdCAM. Some 
overlay with BP3 and little immunofluorescence for CD21/35, Upper and middle row show single 
stainings, lower row showsoverlay. Scale bar 100um 
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preFDCs, but also stained additional cells in the T cell zone (Fig. 3 D). PrP was 
highly expressed on mature FDCs, but immunofluorescence did not detect PrP present 
on other cell types (data not shown). Under certain conditions, such as thioglycollate 
stimulations or in vitro culture (data not published, not shown), macrophages were 
shown to upregulate Mfge8 (Hanayama et al. 2002). I therefore wanted to exclude 
that Mfge8 in the MZ is derived from MZ residing macrophage populations. MOMA-
1+ metallophilic macrophages and ERTR-9+ MZ macrophages did not co-localize 
with Mfge8 (Fig. 4). 
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preFDC are radioresistant and stromal 
To further substantiate the close kinship between the two cell populations, I explored 
the origin, and the radiation sensitivity. Therefore, I generated BM chimaeras of WT 
and Mfge8-/- mice. 8 weeks after engraftment, mice were analyzed for the presence of 
Mfge8+ cells by ISH. As published already for mature FDCs (Kranich et al. 2008), all 
Mfge8+ cells, including the MS lining cells and the cells within the T cell zone are 
derived from a non-hematopoietic, radiorestistant compartment (Fig. 5).  
Fig. 5 Mfge8 is made by stromal, radioresistant cells 
WT and Mfge8-/- mice were lethally irradiated and reconstituted with BM from the Mfge8-/- or WT 
donors, respectively. Mice were immunized and boosted with Ova-Alum. Splenic sections of mice 
were then analyzed for the presence of Mfge8 RNA and protein using Mfge8 AS probe and the FDC-
M1 antibody. Scale bar 100um. 
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Fig. 6 Development of preFDCs depends strongly on LTR 
Consecutive sections of a WT (A), Tnfr1-/- (B), Lta-/- (C), Ltbr-/- (D) spleen where stained with HE 
(left), hybridized with a DIG-labelled AS probe for Mfge8 (second from left), or immunostained for 
CD21/35 (B cells and FDCs) and CD3 (T cells). Mature FDC networks (*) and cells lining the MS 
and within the follicle are indicated with arrows. Scale bar 100m. 
preFDCs ARE PRESENT BEFORE MATURE FDCs EMERGE 
Development of preFDCs relies on LTR signalling but is independent 
from TNFR1 activation 
LN and splenic development is strongly impaired by an absence of LTR signalling: 
LNs do not form, and splenic architecture is heavily disturbed. The effect of TNFR1 
deficiency is less pronounced. Here, LNs do develop, and the cellular composition as 
well as their localization less disturbed. Having this in my mind, I was wondering 
whether preFDC development was dependent on either receptor signalling, and 
analyzed spleens from Tnfa-/- (data not shown), Tnfr1-/-, Lta-/-, Ltb-/-, and Ltbr-/- (Fig. 
6). The pool of preFDCs seemed unchanged in mice lacking TNFR1 signalling. Here, 
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Fig. 7 Cells expressing Mfge8 and Blc in TNFR1 and LTR signalling deficient mice 
ISH for Mfge8 (left row) and Blc (middle row) was performed on consecutive sections of splenic 
sections from Tnfr1-/-, Lta-/-, Ltb-/-, and Ltbr-/- mice. * indicate central arteriole. Arrows point to Blc 
expressing cells within white pulp follicles. Scalce bar 100m. 
Mfge8+ cells were present in the MZ and the T cell area just like in WT spleens. The 
amount of cells present in mice with a LTR signalling deficiency was drastically 
reduced, and the remaining Mfge8+ cells were localized to white pulp follicles. A 
similar distribution of Blc+ cells was observed in the different LT/TNF deficient mice. 
While Tnfr1-/- mice retained many cells lining the follicular sinus, mice with a lack in 
LTR signalling, had only very few cells distributed within follicular structures (Fig. 
7).  
LN development rests upon presence of LT. The analysis of FDC-like cells in 
LNs using Mfge8 AS probe was therefore restricted to WT and Tnfr1-/- mice, which 
retain LNs, however, devoid of mature FDCs. ISH revealed that not only the B cell 
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follicles contained Mfge8+  FDC networks, but that cells positive for this RNA could 
be found in cortex and medulla of WT LNs (Fig. 8). Furthermore, Mfge8+ cells were 
highly abundant in Tnfr1-/- mesenteric LNs (MLNs), indicating again that preFDCs do 
not depend on TNFR1 signalling. Quantitative measurements for Mfge8 in LNs of 
Tnfr1-/- compared to WT 
mice revealed a trend in 
reduction of Mfge8 in 
MLNs from Tnfr1-/- of 
approximately 30%, 
though this was not 
significant (Fig. 8). Only 
ILNs had a significant 
reduction to 80% of WT 
ILN. I concluded from 
these results, that though 
TNFR1 activation is a 
main factor needed for the 
generation of mature 
FDCs, preFDCs in spleens 
and LNs develop 
independently. Especially 
MLNs maintained a very 
high expression of Mfge8 
levels in the absence of TNFR1. In contrast to peripheral LNs, MLNs were shown to 
even develop in the absence of LT underlining their uncommon development. In line 
with this is our observation that the expression of the FDC marker Mfge8 in Tnfr1-/- 
remained largely unaffected. The relative amount of Mfge8 in WT LNs was increased 
compared to splenic tissue. This is most probably due to the fact that splenic tissue is 
Fig. 8 FDCs and preFDCs in LNs of WT and Tnfr1-/- mice 
ISH for Mfge8 on WT (upper left) and Tnfr1-/- (lower left) MLN. Consecutive sections were stained 
with HE. ISH not only detected cells in the B cell follicles but also lining the subcapsular sinus and all 
over the cortex and medulla of the LN. Scale bar 100m. Graph shows relative amounts of Mfge8 
mRNA from WT and Tnfr1-/- inguinal LN and MLN normalized over Gapdh and Mfge8 levels of WT 
MLN. In total the relative expression in LNs is slightly higher than in a WT spleen (SP). Unpaired-t 
test * p≤0.05. 
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made of lymphoid, but also non-lymphoid compartments. Though total amount of 
white pulp content of a spleen is higher than in a LN, the relative expression of white 
pulp markers is reduced. 
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preFDCs’ maintenance in WT and Tnfr1-/- depends on LTR activation 
LTR signalling can be blocked using a soluble decoy LTR fused to an 
immunoglobulin domain (LTR-Ig) competing with the endogenous receptor for the 
ligands. Treatment of mice for 24h with LTR-Ig leads to dedifferentiation of FDCs, 
including the loss of classical FDCs markers and trapped antigen in the spleen 
(Mackay and Browning 1998). Furthermore, marginal sinus MAdCAM+ cells are 
absent after blocking of LTR. In mice treated with a decoy TNFR1, the amount of 
bound ICs is diminished as well, nevertheless, mature FDC networks remain (Mackay 
and Browning 1998). I was therefore interested to see whether the maintenance of 
preFDCs depended on the persistent activation of LTR signalling and treated WT as 
well as Tnfr1-/- mice with soluble LTR -Igs or isotype control. Blockage of LTR 
Fig. 9 Maintenance of preFDCs depends on the expression of LTR 
(A) WT mice were treated for three weeks with 100g LTR-Ig or respective isotype control i.p, 
weekly. ISH for Mfge8 was carried out on splenic cryosections, consecutive sections were stained by 
IHC for CD21/35 and CD3. Mfge8 RNA is down-regulated to 20% (0.2±0.1; n=3) compared to Mfge8 
expression in isotype treated WT mice (fold change 1±0.37). (B) Treatment of Tnfr1-/- mice for 1 week 
with 100g LTR-Ig or respective isotype i.v (n=5). Spleens were analyzed by Mfge8 ISH and qPCR. 
Blocking LTR activity lead to a 90% reduction in Mfge8 expression (fold change 0.09±0.03) 
compared to isotype treated (fold change 1.00±0.30). Unpaired-t test * p≤0.05, *** p≤0.001. Scale bar 
100m. 
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activation resulted in the loss of preFDCs in, both, WT and Tnfr1-/- mice (Fig. 9). 
FDCs are important for the proper localization of follicular B cells, attracting them via 
BLC. Interestingly, it had been previously shown that the adhesion molecules ICAM-
1 and VCAM-1 are important for the localization of MZ B cells, and furthermore that 
LTR signalling was needed for the ICAM-1 and VCAM-1 expression in the spleen 
and treatment with LTR-Ig would hence result in the dislodgement of MZ B cells. 
Since preFDCs are expressing ICAM-1 (Fig. 3) they could be the cells responsible for 
the accumulation of MZ B cells. Blocking of LTR signalling in a WT spleen, as it 
was done by the group of Cyster, however, not only alters the cellular composition in 
the MS, but also leads to the dedifferentiation of FDCs. I therefore wanted to test, 
whether the dedifferentiation of preFDCs, only, would also result in the release MZ B 
cells. For this purpose I treated Tnfr1-/- mice either with LTR-Ig or isotype control 
and determined the percentage of MZ B cells (CD21high/CD23low) per total B cells 
(CD19) by FACS (Fig. 10). Indeed the loss of preFDCs in Tnfr1-/- mice correlated 
with a loss of MZ B cells by approximately 60%, supporting the hypothesis that 
preFDCs are regulating the lodgement of MZ B cells. 
 
Fig. 10 MZ B cells depend on LTR activation 
Tnfr1-/- mice were either treated with 100g LTR-Ig (n=5) or hamster isotype (n=6) i.v. for 1 week. 
Percentage of MZ B cells (CD19+CD21highCD23low) of total B cells (CD19) was determined. Tnfr1-/- 
LTR-Ig treated mice (mean % 2.1±0.5) had significantly reduced amounts of MZ B cells compared 
to isotype treated mice (mean % of MZ B cells 6.5±1). Unpaired t-test *** p≤0.001 
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preFDCs are present in mice lacking lymphocytes 
The abolishment of parts of the TNF superfamily affected the development of FDC-
like cells to different extents. Lymphocytes, especially B cells, are the major cell type 
supplying the SLOs with LT, LT3, and TNF. I had observed that LTR 
activation was needed to maintain preFDCs as well as MZ B cells in WT and Tnfr1-/- 
mice. On the other hand, the presence of B cells, supplying SLOs with LTsis needed 
for FDCs to develop and to be maintained as was shown in mice lacking B cells by 
conditional targeting or in mice where B cells were ablated temporarily using anti-
IgM antibodies (Cerny et al. 1988). Hence, MZ B cells might be involved in the 
establishment and maintenance of preFDCs. Compared to follicular B cells, MZ B 
cells express increased amounts of integrin receptors, 41 (VLA-4) and L2 
(LFA-1). In vitro adhesion tests had shown that these integrins on the MZ B cells 
mediate the attachment to the adhesion molecules VCAM-1 and ICAM-1. In vivo the 
injection of antibodies interfering with the binding to just one of the adhesion 
molecules, is insufficient to release MZ B cells. However, injection of antibodies 
blocking both simultaneously, results in the loss of this cell population within few 
hours, and re-emergence of MZ B cells is blocked for more than 4 days (Lu and 
Cyster 2002). To test whether the presence of MZ B cells was needed for preFDCs’ 
maintenance, I ablated MZ B cells using either a combination of anti-integrin 
L/VCAM-1 or anti-integrin L/4 antibodies (Fig. 11). After 4 days, mice were 
sacrificed, and the spleens assessed for the presence of MZ B cells by determining the 
ratio of CD21highCD23lowCD19+ MZ B cells over total CD19+ B cells by FACS and 
the amount of Mfge8 RNA as well as the distribution of Mfge8+  preFDCs by qPCR 
and ISH. After blocking ICAM-1 and VCAM-1 interactions the amount of MZ B cells 
was drastically reduced, surprisingly, total levels of Mfge8 or the distribution of FDCs 
and preFDCs remained unaltered. This result could indicate that though MZ B cells 
are important for preFDC, their ablation using the antibodies was incomplete or too 
short term to result in a dedifferentiation of preFDCs or on the other hand could 
suggest that preFDCs do not depend on MZ B cells after all.  
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Fig. 11 Ablation of MZ B cells does not affect preFDCs 
Mice were treated for 4 days with 100g of anti-integrin L in combination with anti- integrin 4 
(anti-L/4) or anti-VCAM-1 (anti-L/VCAM or anti-L/V) antibodies or the respective isotype 
(iso) controls (n=5 each group). Mice were sacrificed and spleens analysed by FACS (A) or histology 
and qPCR (B). Percentage of MZ B cells (CD19+CD21highCD23low) of total B cells (CD19) was 
determined. Tnfr1-/-. anti-L/VCAM-1 treated mice (mean % of MZ B cells 0.4±0.1) and anti-L/4 
treated (mean % of MZ B cells 0.1±0.0) had significantly reduced numbers compared to their 
respective isotype treated mice (mean % of MZ B cells in anti-L/VCAM-1 iso 3.2±0.2, in anti-
L/4 iso 3.2±0.8). (B) ISH for Mfge8 on splenic cryosections of WT mice treated with different 
antibody combinations. Right panel qPCR for relative expression of Mfge8 in spleens from 
VCAM/ICAM blocked mice normalized over isotype treated mice. Differences were not significant. 
Unpaired t-test *** p≤0.001 
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 Because lack in TLR signalling was reported to affect the microarchitecture of 
the splenic MZ, with decreased amounts of MZ B cells, I investigated spleens of mice 
lacking MyD88, an adaptor protein needed for the downstream signalling events of 
TLR (Fig.12) (Prinz et al. 2003). The distribution of preFDCs in these mice however 
remained unaltered, thus long term changes in the MZ microarchitecture do not affect 
preFDCs either. 
Fig. 12 Presence of preFDCs in Myd88-/- spleens 
Spleens from Myd88-deficient mice were analyzed by ISH for Mfge8 for the presence of 
preFDCs. Consecutive sections were stained with HE or with the Mfge8 sense probe as a 
negative control (Mfge8 S), Dapi staining war performed on the section hybridized with 
Mfge8 S probe.
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The ablation of MZ B cells thus had no effect on preFDCs. MZ B cell however only 
constitute the minor amount of splenic B cells, and the remaining B cells might 
supply preFDCs with factors including LT. We therefore investigated the role of a 
constitutive ablation of all B lymphocytes, analyzing MTD mice (deletion of the 
membrane domain of IgM heavy chain results in a developmental block), but also the 
consequence of the ablation of both, B and T cells, (Rag1-/-: lacking the recombinase 
activating gene 1) on the development of putative FDC precursors. ISH for Mfge8 and 
Blc was performed on splenic sections from these knock out mice (Fig. 13 and Fig. 
14). Despite the diminished size of white pulp follicles in MTD and Rag1-/- spleens, 
preFDCs were retained, thus other cells than B and T cells must be relevant for the 
development of preFDCs. To test whether ablation of further cell populations would 
affect the presence of preFDCs, Rag2-/-c-/- spleens were investigated. In addition to 
Rag2 (Recombinase activating gene 2), these mice lack the common cytokine receptor 
Fig. 13 Mfge8 ISH on splenic sections of mice lacking lymphocyte populations 
Mice lacking B cells MTD, A), B and T cells (Rag1-/-, B) B, T and NK cells (Rag2-/-c-/-, C) were 
analyzed for the presence of Mfge8+ preFDCs and proFDCs (second row left) by performing Mfge8 
ISH on splenic sections. Consecutive sections were stained with HE, CD21/35 (B cells) and CD3 (T 
cells). Arrows indicate proFDC clusters. Scale bar 100m. 
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gamma chain (c). c is part of the interleukin (IL)-2, IL-4, IL-7, IL-9, and IL-15 
receptor, and its absence leads in a developmental block of B and T cells as well as 
loss of all NK cells (Cao et al. 1995; DiSanto et al. 1995; Ohbo et al. 1996). Rag2-/-c-
/-, furthermore, do not develop any LNs and have no follicular structures in the spleen. 
The spleens of these mice had strongly reduced numbers of Mfge8+Blc+ cells, residual 
ones were clustering around vascular structures (Fig. 9 C, Fig. 10 C). To distinguish 
between the MS and follicular preFDCs, and the less developed perivascular 
Mfge8+Blc+ cells of Rag2-/-c-/- mice, we termed the latter proFDCs. These results 
suggest, that in contrast to mature FDCs, preFDC development is not only 
independent from TNFR1 signalling, but even occurs in mice lacking B cells, thus in 
the absence of the cell, providing the major amount of local TNF, LT, and LT 
Even though, T cells were also reported to produce some LT, the additional 
ablation of T lymphocytes did not seem to alter pre FDC distribution. 
Fig. 14 proFDCs and preFDCs in mice lacking lymphocytes express Mfge8 and Blc 
Consecutive sections from MTD, Rag1-/- and Rag2-/-c-/- were hybridized with antisense probes 
against Mfge8 and Blc or stained with HE. * indicate vessels, arrows point to Mfge8+ and Blc+ 
proFDCs. Scale bar 100m. 
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Fig. 15 Expression of FDC markers determined by quantitative RT PCR 
Spleens from WT and different mutants were isolated, purified RNA was reverse-transcribed (RT) 
into cDNA. qPCR for Mfge8 (A), Blc (B), Clusterin (C), Igfbp3 (D), Cd21 (E) were performed n=3 
except Ltbr-/- n=2. Graphs show relative expression to WT spleen, all PCR results were normalized 
over Gapdh. unpaired t-test. A-D all mutants show significant reduction compared to WT (not 
indicated). n.s. not significant * p≤0.05, ** p≤0.01, *** p≤0.001 
Precursor FDCs are blocked at two different stages 
ISH had already shown that putative FDC precursors are present to different degrees 
in the different mouse mutants. I therefore wanted to assess, whether quantitative 
measurements could be used to determine distinct development stages. Thus I isolated 
RNA from splenic tissue and generated complementary DNA (cDNA) to quantify by 
quantitative PCR the amount of FDC markers to be expressed in splenic tissue from 
the respective mutants and compared it to the WT expression pattern. FDC marker to 
be chosen, were Mfge8 and BLC to confirm the results obtained by ISH, as well as 
Clusterin and Igfbp3, FDC-specific mRNAs as published previously (Huber et al. 
2005), as well as the complement receptor Cd21, needed for IC-trapping by mature 
FDCs. Mfge8, Blc, Clusterin and Igfbp3, showed all a significant reduction in the 
mutant mouse strains compared to WT mice (Fig. 15 A-D). Mutant mice segregated 
into two groups according to the expression of these RNAs. Rag1-/-, MTD, and Tnfr1-
/- showed higher expression of these FDC markers than Rag2-/-c-/-, Lta-/-, Ltb-/-, and 
Ltbr-/-, reflecting the more severe developmental block in the latter group. In contrast 
Cd21 expression behaved very differently (Fig. 15 E). While Tnfr1-/-expressed at WT 
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Fig. 16 LTR activation is essential for Mfge8 expressing cells in Rag2-/-c-/-
(A, B) Comparison of Lta and Tnfa mRNA expression in spleens from indicated mutants by qPCR. 
Lta-/-, and Tnfa-/- spleens were used to determine threshold of detection. Unpaired t-test. n.s. not 
significant * p≤0.05. (C) Treatment of Rag2-/-c-/- and WT mice with agonistic LTR antibody 
(AC.H6) or hamster isotype control, 50g i.v. for 24h. Spleens were analyzed for Mfge8 expression 
by qPCR, normalized over Gapdh and isotype control. Difference was not significant according to 
unpaired t-test. 
levels, Lta-/-, Ltb-/-, and Ltbr-/- had a reduction to some extent (ranging from 25-75% 
of WT levels). In Rag1-/-, MTD, and Rag2-/-c-/- mice no apparent Cd21 expression 
was detectable, indicating that even though Rag1-/-, and MTD mice have the more 
developed preFDCs present, these cells do not express the FDC marker Cd21 yet, but 
that Cd21 expression is confined to B cells and mature FDCs.  
LT is decreased in Rag2-/-c-/- and LTR activation stimulates Mfge8 
expression 
To understand the cellular signalling events which advance the development from pro 
to preFDCs as it is seen in Rag1-/- compared to Rag2-/-c-/-, we assessed differences in 
mRNA expression by qPCR. Because the main signalling pathways involved in LN 
development, in the generation of the splenic microarchitecture and FDCs are based 
on TNF family members, we analyzed the expression of Lta and Tnfa RNA, the 
ligands needed for LTR and TNFR1 activation (Fig. 16 A and B). Rag1-/-, and MTD 
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had an apparent reduction of Lta and Tnfa expression to 10-20% of WT levels, 
confirming the important role of B cells in supplying SLOs with ligands for LTR 
and TNFR1. Reduction of mRNA for both TNF family ligands to 10% of WT 
expression thus correlated with the reduction of several FDC markers to 15-50% of 
WT (Fig. 15). Analysis of the Rag2-/-c-/- showed that spleens from these mice had an 
even more dramatic loss in Lta mRNA to less than 1% of WT expression, but Tnfa 
mRNA remained nearly unaltered compared to Rag1-/-. This indicated that LTR 
activation and not TNFR1 activation is needed for the first expansion of proFDCs. To 
test this hypothesis, Rag2-/-c-/-, lacking LTR signalling, and WT mice, sufficiently 
supplied with LTR activation, were stimulated for 24h with 50ug of an agonistic 
anti-LTR antibody. Next, splenic Mfge8 expression in the spleen was determined 
(Fig. 16 C). Agonist treatment upregulated Mfge8 mRNA in Rag2-/-c-/- spleens 
approximately 250-fold compared to isotype treated mice. In WT mice, however, no 
change in expression was observed, indicating that the antibody cannot compete with 
the endogenous ligands for the binding to LTR or signalling is at its maximum. The 
results obtained from the Rag2-/-c-/- treated with an agonistic anti-LTR antibody 
indicate that LT signalling is already essential for early pro to preFDC development. 
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Fig. 17 preFDCs are independent from NK cells 
Ablation of NKs from Rag1-/-mice using anti-NK1.1 or isotype control antibody applied weekly over a 
time of 3 weeks. Spleens were analyzed for the depletion of NK cells by FACS using NK1.1 and pan-
NK marker DX5 (A, left). Picture is representative for the respective group. Quantification of 
NK1.1/DX5+ cells over total lymphocyte population shows the very significant loss of NK cells (A, 
right). NK1.1 treated group n=5, isotype n=3. (B) Relative Mfge8 expression in the two groups to WT 
expression and Rag1-/- . Unpaired T-test. n.s. not significant, *** p≤0.001. ISH for Mfge8 in Rag1-/- 
treated with isotype antibody (upper row) or NK depleted (lower row). Consecutive sections were 
either HE stained or hybridized with Mfge8 AS probe. 
Natural killer cells are dispensable for preFDCs 
LT signalling seemed to majorly affected in Rag2-/-c-/- mice, while Rag1-/- could 
maintain 10% of the WT expression, which was sufficient to keep preFDCs 
differentiated. The cellular source of LT in mice lacking B cells remained unknown. 
c-deficiency results in the absence of NK cells, and activated human NK cells 
were reported to express LT (Ware et al. 1992). Therefore, we wondered whether the 
difference between Rag1-/- preFDCs and Rag2-/-c-/- proFDCs was due to a lack of NK 
cells. To test this, we depleted NK cells from Rag1-/- mice treating them for 3 weeks 
with an anti-NK1.1 antibody (Strick-Marchand et al. 2008). Depletion was confirmed 
by FACS using NK1.1 and DX5 as pan-NK markers, the NK population was reduced 
to less than 1% of the total lymphocytes, while in isotype control treated mice 
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approximately 50% of the lymphocytes were NK cells (Fig. 17 A). Expression of 
Mfge8 mRNA was determined in anti-NK1.1 antibody and isotype control treated 
groups (Fig. 17 B). No significant difference was detected. However, treatment with 
either of the antibodies resulted in a slight downregulation of Mfge8 as determined by 
qPCR, suggesting that the antibody per se had an unknown regulatory effect on Mfge8 
expression. ISH for Mfge8 showed that both groups had remaining follicles containing 
preFDCs, supporting that the absence of NK cells did not alter the amount of 
preFDCs nor their localization (Fig. 17 C). 
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LTis are altered in Rag2-/-c-/- and LTis determine the presence of 
preFDCs in Rag1-/- 
Common cytokine deficiency leads to a signalling deficiency of a multitude of IL-Rs, 
including the receptors for IL2, IL-7, and IL15. More recently it could be shown that 
Fig. 18 Determining the number of LTis in WT, Rag1-/-, Rag2-/-c-/- spleens 
(A) Spleens from WT, Rag1-/-, and Rag2-/-c-/- were analyzed by FACS for the presence of LTis. 
Figures show a representative picture of each group (n=3). The live gate was set using FSC/SSC 
(upper row), within the live gate, CD3+ and B220+ cells were excluded, and relative numbers of 
CD3-B220-CD4+IL-7R+ LTis are shown in dot blot (middle row). Total numbers of LTis over live 
cells from the spleen were then calculated (lowest row). (B) Determination of LTi specific Cd30l 
RNA by qPCR shows significant reduction in Rag2-/-c-/- spleens. Unpaired t-test ** p≤0.01 
                                                                                RESULTS 
_____________________________________________________________________ 
                                                                                                                             58
 
signalling via IL2R, but more importantly IL15R is crucial for the generation of NK 
cells, while IL-7R is dispensable for NK cells development (He and Malek 1996; 
Ohteki et al. 1997). The IL-7R is highly abundant on lymphoid tissue inducer cells 
(LTis), the cells needed for the induction of LNs and PPs (Cong et al. 2001; 
Fukuyama et al. 2002; Cupedo et al. 2004; Eberl et al. 2004). Spleens of mice lacking 
LTis, develop normally, but contain more lymphocytes that WT spleens (Zhang et al. 
2003). LTis express LT, and recently it was found that deficiency of the IL-7R 
chain results in a reduction of total LTi numbers, and that cells with higher expression 
of IL-7R have more LT present on their surface (Luther et al. 2003). In line with 
this, the total LTi number and the expression of cytokines such as CD30L in Rag2-/-
c-/- was reported to be reduced when compared to Rag1-/- mice, adding additional 
evidence for LTis’ dependence on IL-7R- signalling (Kim et al. 2005; Takatori et al. 
2009). We determined total LTi numbers isolated from WT, Rag1-/-, and Rag2-/-c-/- 
and confirmed a reduced amount in Rag2-/-c-/- spleens (Fig. 18). Quantification of 
splenic Cd30l mRNA revealed a significant loss in Rag2-/-c-/- indicating that LTis are 
dysfunctional.  
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To test whether preFDCs depend on LTis, mice lacking LTis by gene targeting of the 
retinoid-related orphan receptor gamma (Rorc(t)GFP/GFP) were analyzed by Mfge8 
ISH (Eberl et al. 2004). Though LTis are present in WT spleens, Rorc(t)GFP/GFP mice 
were reported to have a normal microarchitecture of the spleen. We could also 
confirm that they contained mature FDC clusters as well as preFDCs around the MS 
as well as in the T cell zone, hence LTi function is not needed for the development of 
the splenic microarchitecture in WT mice (Fig. 19). In contrast to LNs, where 
Fig. 19 FDCs and preFDCs develop normally in the absence of RORt
Splenic sections from a Rorc(t)GFP/GFP mouse was either hybridized with Mfge8 AS probe or stained 
with HE. ISH results shows that Rorc(t)GFP/GFP have normal development of mature FDC networks as 
well as of the preFDC compartment. Scale bar 100m. 
Fig. 20 preFDCs depend on LTis in the absence of lymphocytes
Splenic sections from Rag1-/-Rorc(t)GFP/+ (A) were compared to Rag1-/-Rorc(t)GFP/GFP (B) were 
hybridized with an Mfge8 AS. ISH results shows that Rag1-/-Rorc(t)GFP/GFP still maintain follicle like 
structures, similar as in Rag1-/- (Fig. 13), which are not maintained in Rag1-/-Rorc(t)GFP/GFP lacking all 
follicular structures. Here, only few single cells expressing Mfge8 can be detected. Scale bar 100m. 
(C) Relative expression of splenic Mfge8 expression in Rag1-/-Rorc(t)GFP/GFP compared to Rag1-/-
Rorc(t)GFP/+ normalized over Gapdh. Unpaired t-test determined a significant reduction p≤0.01 
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embryonic LT made by LTis is needed to induce their development, the white pulp of 
the spleen develops postnatally, at a time point, when naïve B cells start to be present. 
The function of LTis in the spleen might therefore be compensated by B lymphocytes, 
expressing ligands of the TNF family. In the absence of B cells, the remaining cellular 
source of TNF family ligands is likely to be the LTi. To assess whether LTis are 
required for the presence of preFDCs present in Rag1-/- mice, Rag1-/- mice were 
backcrossed to Rorc(t)GFP/GFP mice and compared to Rorc(t)GFP/+ littermates (Fig. 
20). Indeed mice lacking LTis in the absence of lymphocytes showed a dramatic loss 
in preFDCs, and follicular structures were no longer apparent. qPCR confirmed the 
reduction in FDC markers. Thus, the presence of LTis results in the generation of 
follicular structures and the maturation of pro to preFDCs. 
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FDCs HAVE A PERIVASCULAR ORIGIN 
Analysis of the FDC development in BM reconstituted Rag2-/-c-/-  
Now that the cellular factors and signaling pathways were resolved we were interested 
in the localization of the earliest proFDC and their development and the maturation of 
FDCs. To follow the ontogeny of FDCs in situ, Rag2-/-c-/- mice were reconstituted 
with BM derived from WT donors, to supply them with all the lymphocyte 
populations and LT, which are usually absent in these mice. This environment in turn 
supports the development of splenic FDCs, which I set out to follow the days after 
BM transfer. Mice were analyzed starting from day 2 onwards by Mfge8 ISH as well 
as by IHC for CD21/35, B220 and CD3 to follow the influx and maturation of 
lymphocytes and FDCs (Fig. 21). As mentioned previously, unreconstituted Rag2-/-c-
/- mice have proFDC clusters localizing next to vascular structures. Upon intravenous 
(i.v.) transfer of BM, lymphocytes entered the spleen at the site of proFDCs. Hand in 
hand with the arrival of lymphocytes I determined an increase in proFDCs at 
perivascular sites. proFDCs were observed along long stretches of vessels. At later 
Fig. 21 Induction of FDC development in Rag2-/-c-/- mice by WT BM transfer 
Rag2-/-c-/- mice were reconstituted with WT BM without irradiation and mice sacrificed at different 
days after transfer of BM. Mfge8 ISH was performed on these mice to determine the FDC 
development status (A). Consecutive sections at day 3 post BM transfer (B) and at day 13 (C) were 
stained with the B and FDC cell marker CD21/35, B220, for T cells CD3 staining was performed. 
Scale bar 100m. 
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time points, perivascular accumulations of FDC precursors and lymphocytes started 
budding off from vascular structures and generate white pulp (WP) follicles. In Rag2-
/-c-/- mice reconstituted with Lta-/- BM, the B cell influx was delayed, few of them 
expressed CD21/35. proFDCs were localized within the developing follicles, their 
population, however, did not expand markedly (Fig. 22). These results corroborate 
that the very early induction of proFDCs depends on LTR activation, and that in its 
absence the positive feedback loop of chemokines and signaling molecules between 
hematopoietic and stromal compartment is impaired.  
Fig. 22 Absence of preFDC development in Rag2-/-c-/- mice by Lta-/- BM transfer 
Rag2-/-c-/- mice were reconstituted with Lta-/- BM without irradiation and mice sacrificed at different 
days post transfer of BM. Mfge8 ISH was performed on these mice to determine the FDC 
development status (A). Consecutive sections at day 3 post BM transfer (B) and at day 13 (C) were 
stained with the B and FDC cell marker CD21/35, B220, for T cells CD3 staining was performed. 
Though lymphocytes were infiltrating at sites where proFDCs were present, the influx of B cells was 
reduced compared to T cells and the upregulation of the mature B cell marker CD21/35 was strongly 
delayed. proFDCs did not expand efficiently. Scale bar 100m. 
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Fig. 23 Development of FDCs in the postnatal spleen 
Analysis of postnatal spleens by ISH for Mfge8, IHC for CD21/35, B220, and CD3, was performed to 
assess the development of the hemaopoietic compartment. At postnatal day 0 (P0, A) no Mfge8 
expression could be observed. At P2 (B) Mfge8 expressing cells were detected at perivascular sites, in 
the presence of lymphocytes expressing B200 and CD3. P10 (C) follicular structures were present and 
B cells started to express CD21/35, segregation into B and T cell zones were observed. P14 (D) 
CD21/35 high clusters were detected within the FDC network. Scale bar 100m  
Postnatal development of FDCs  
Because the development of FDCs upon reconstitution Rag2-/-c-/- mice with WT BM 
might not reflect events that occur under normal circumstances, we decided to analyze 
the development of FDCs in the developing WP of WT mice. In contrast to the LNs, 
the splenic WP is not formed during embryogenesis of the mouse, but develops 
postnatally. We therefore analyzed the development of FDCs by Mfge8 ISH starting 
from postnatal day 0 (P0). Consecutive sections were stained with CD21/35 to 
determine the status of FDC and B cell maturation, B220 and CD3 were used to detect 
B and T lymphocytes, respectively. At P0 (Fig. 23 A) and P1 (data not shown), no 
Mfge8 expressing cells were found, only by P2 Mfge8+  cells could be detected 
appearing around vascular sites, co-localizing with entry sites of B and T cells (Fig. 
23 B). B cells present in the first postnatal week did not express CD21/35 indicating 
that they were still not fully mature, but early transitional (T1) B cells (Loder et al. 
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1999). By P10 follicular structures could be found and CD21/35 was increasingly 
present, reflecting the more mature state of the B cells present (Fig. 23 C). At P14 
FDC clusters with high CD21/35 expression were present within the follicles, B and T 
cell separation had occurred (Fig. 23 D). 
FDCs are derived from a Pdgfrb expressing cell 
Previous results pointed to a perivascular origin of the mature FDC: the earliest 
Mfge8+ cells were accumulating along vessels, and transitional forms between 
perivascular, MS lining and follicular Mfge8 expressing cells were observed. Within 
the perivascular niche, mesenchymal pericytes were shown to be multipotent cells, 
which could differentiate into different cell types including fibroblasts (Dellavalle et 
al. 2007; Lin et al. 2008; Tang et al. 2008). To test for a perivascular origin of FDCs, 
we used pericyte reporter mice. PDGFR is a receptor expressed specifically in 
Fig. 24 Using a pericyte reporter mouse to determine the origin of FDCs  
Spleens from Pdgfrb-Cre+ R26R+ (upper row) and Pdgfrb-Cre- R26R+ (lower row) littermate (n=1) 
were stained for -Gal activity (left), consecutive sections were stained for FDC-M1 (right) do detect 
FDCs. -Gal activity was found in the areas of mature FDC networks but also in the MS and the RP. 
Scale bar 100m. 
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pericytes of different organs. We used Pdgfrb-Cre transgenic, crossed to a Cre 
reporter mouse expressing beta galactosidase (-Gal) as a result of Cre activity (Fig. 
24). Consecutive splenic sections were either stained for -Gal activity or FDC-M1. 
The FDC marker co-localized to the same areas as the -Gal staining did. FDCs 
express or must have expressed Pdgfrb at some time during their development, 
suggesting that FDCs are related to pericyte cells or are even of pericyte origin.  
preFDCs express pericyte markers 
To test whether mature FDCs and preFDCs were maintaining a pericyte character, co-
immunofluorescence for the pericyte markers alpha smooth muscle actin (SMA), 
chondroitin sulfate proteoglycan NG2 as well as PDGFRwith Mfge8 was 
performed. Interestingly, mature FDCs showed little expression of any of these 
markers, while preFDCs in the MS exhibited SMA and PDGFR expression, but were 
negative for NG2 (Fig. 25). This indicates that during early development future FDCs 
express pericyte markers, but downregulate these during further differentiation into 
mature FDCs. As pericytes do not always express all the reported markers, this might 
explain why the NG2 expression in the spleen is present to a much lesser extent than 
SMA or PDGFR are. 
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Fig. 25 Expression of pericyte markers in the spleen 
Co-immunofluorescence on WT spleens of Mfge8 with the pericyte markers SMA (A), NG2 (B) and 
PDGFR (C) were performed. Mature FDCs showed little expression of pericyte markers, but 
preFDCs in the MS expressed SMA and PDGFR. Arrows point to preFDC with pericyte marker 
expression. * indicates central arteriole. Scale bar 100m. 
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Mfge8 expressing cells in liver and kidney 
Because ectopic 
expression of LT 
leads to the 
induction of tertiary 
lymphoid follicles 
in non-lymphoid 
organs, such as 
liver, and kidney, I 
was interested to see 
whether putative 
proFDCs were 
present. We wanted 
to see whether 
Mfge8 expressing 
cells were found in 
situ, whether these 
depended on LTR 
activation, and 
whether changes in 
the presence of 
LTR activation 
could be observed. 
Studying WT livers 
I realized that 
Claudin7+ oval cells, 
also know as biliary cells of liver, expressed Mfge8 (Fig. 26). Interestingly, oval cells 
expressing Mfge8, were also found in Ltbr-/-, thus steady-state Mfge8 levels in the 
liver are independent of Ltbr-/- (Fig. 27). As reported these mice have inflammatory 
foci in their livers containing T and B cells without development of FDCs. Often 
these inflammatory foci seemed to localize to oval cell areas. Since FDCs were 
reported to develop in livers upon presence of LT, we tried to simulate an 
Fig. 26 Expression of Mfge8 in the WT liver 
ISH for Mfge8 was performed on WT livers (A), and Mfge8-/- livers (B). 
Consecutive sections were either hybridized with a negative control 
sense probe (Mfge8 S), stained with HE, or the oval cell marker Claudin 
7. Scale bar 100m.  
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environment of FDC induction by treating WT mice with agonistic anti-LTR 
antibody. We found that compared to isotype control treated mice 24h after i.v. 
treatment, Mfge8 was upregulated approximately 9 fold in agonist treated livers. Oval 
cells showed a strong Mfge8+  signal, but also cells throughout the liver started to 
express Mfge8, while isotype control treated mice had unaltered expression restricted 
to oval cells only (Fig. 28). Whether these cells represent already differentiated FDCs 
or stellate cells, the liver pericytes, which have a dendritic appearance, remains to be 
shown.  
 
 
 
Fig. 27 Expression of Mfge8 in the absence of LTR activation 
ISH for Mfge8 on liver sections of Ltbr-/- mice, counterstained with Dapi. Consecutive sections 
hybridized with sense probe. Higher magnification picture shows that oval cells next to the portal field 
are surrounded by lymphocytic infiltrates, typically seen in Ltbr-/- mice. Scale bar 100m. 
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Fig. 28 Induction of Mfge8 expressing cells in the liver 
WT mice were treated for 24h with agonistic anti-LTR antibody or hamster isotype control (n=3). 
Livers were analyzed by Mfge ISH (A): lower magnification (upper row) and higher magnification 
(lower row). Scale bar 100m. The fold change in Mfge8 expression was determined by qPCR, 
normalized over Gapdh and quantified over isotype control. Compared to isotype treated mice (1±0.1 
SD) agonist treated mice showed in mean an increase of. (8.9±5.5 SD). SD standard deviation. 
Statistical analysis using unpaired t-test revealed that the increase was not significant. 
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Furthermore the presence of Mfge8 expressing cells in the kidney was examined by 
ISH (Fig. 29). Indeed, Mfge8+ cells could be detected present in the glomeruli of the 
kidney. The mesangial cells, which are specialized pericytes of the kidney, reside 
within the glomerulum, suggesting that pericytes in different organs might express 
Mfge8.  
 
Fig. 29 Mfge8 expressing cells in the kidney 
Kidney of a WT mouse hybridized with an Mfge8AS probe (left), consecutive section was stained with 
HE (right). Mfge8 RNA is detected within the glomeruli of kidney and might be expressed by 
mesangial cells 
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GENERATION OF BAC TRANSGENIC MICE 
Cloning strategy of BAC transgenic mice 
Several functions have been ascribed to FDCs. Most of them remain sketchy, as there 
are no methods for culturing FDCs in a pure state, and due to a dearth in molecular 
FDC-specific markers, there are no means of targeting FDCs transgenically. We have 
generated first evidence that FDCs are developing from a perivascular pericyte 
expressing Pdgfrb, and that Mfge8 is an early marker for these cells. We have, 
however, no formal proof that early Mfge8 expressing cells in spleen and other organs 
can (and will) develop into mature FDCs. Fate tracing by use of inducible reporter 
mice can be performed to answer this question. To evaluate FDCs’ involvement in the 
establishment of chronic inflammations, or cancer, and their supposedly beneficial 
role in the prevention of autoimmunity, a conditional ablation and genetic targeting of 
FDCs would be advantageous. Also, FDCs play a major role in prion diseases. 
Presence of prions in the spleen and neuroinvasion of prions into the CNS is 
dependent on FDCs. However, whether FDCs indeed replicate PrPSc or merely 
accumulate it, remains to be answered.  
 Therefore, we decided to generate mice expressing different genes of interest 
(GOI) under the Mfge8 promoter. The GOIs are Cre recombinase, tamoxifen-
inducible Cre recombinase, Prnp, tdTomato, Lta, and Ltb.  
Cre (Cyclization Recombination) recombinase is a viral recombinase derived 
from the bacteriophage P1. The Cre recombinase recognizes loxP sites – a loxP site is 
a 34bp DNA sequence containing two palindromic areas. Cre-mediated recombination 
of two loxP sites can be used to delete loxP flanked areas (Gu et al. 1993). In 
transgenic approaches the Cre recombinase can be expressed under a specific 
promoter, a technique, which is frequently used to generate conditional knock outs or 
to restrict a reporter expression to a certain tissue or cell type, which allows the 
tracing of cell populations (Lakso et al. 1992; Gu et al. 1994).  
Inducible Cre-recombinase (CreERT2) is a fusion of Cre recombinase to a 
mutated estrogen receptor (ER). ERT2 has a high affinity for synthetic tamoxifen, but 
does not bind estradiol (Feil et al. 1997). CreERT2 also lacks the endogenous nuclear 
localization signal (NLS). In the absence of the NLS the recombinase remains in the 
cytoplasma, however, hormone-binding results in the nuclear translocation of fusion 
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Fig. 30 Different BACs containing the Mfge8 locus 
NCBI database was searched using clone finder for BACs containing the Mfge8 locus (blue dotted 
lines each represent the fragment of each single BAC). Three different clones used for the generation 
of BAC transgenics are indicated: RP23, RP24 19, and RP24 11. 
protein, where Cre recombinase exerts its function, namely the recombination of loxP 
sites. Thus the expression of CreERT2 under the Mfge8 promoter allows the 
tamoxifen-inducible recombination of LoxP sites with a restriction to Mfge8+ cells, 
making it a useful tool for fate tracing of FDCs.  
Restricting the PrP-expression to FDCs by placing the Prnp gene under the 
Mfge8 promoter, will allow us to tackle the question of FDC-intrinsic prion 
replication capacity.  
tdTomato (tandem dimer), is a strong red fluorescent protein, which will be 
used to follow cells expressing Mfge8 in vivo (Shaner et al. 2008). Fluorescently 
labeled cells will be isolated and cultured in vitro or used for transplantation. The 
Mfge8-tdTomato mouse strain will facilitate understanding cellular interactions and 
signaling mechanism behind FDC development. 
Expression of LT and LT under the Mfge8 promoter will be used to 
investigate whether early FDCs (Mfge8+ cells) can stimulate innate LTR signaling in 
an autocrine or paracrine fashion to generate mature FDCs ectopically in organs such 
as the liver or kidney. 
 As very little is known about the promoter and enhancer areas of Mfge8, we 
decided to generate transgenic mice using Bacterial Artificial Chromosomes (BAC), 
which contain long DNA fragments including the Mfge8 locus and all its regulatory 
regions (Yang et al. 1997). BACs are circular DNA vectors, which enable the 
propagation of large foreign DNA fragments in Escherichia coli (E.coli). The 
corresponding DNA fragments are inserted into a fertility plasmid, which allow the 
RP23  
RP24 19 RP24 11 
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Fig. 31 Schematic depiction of the BAC RP23 
BAC backbone with a 247kb insert of mouse genomic 
DNA containing the Mfge8 locus. Genes are drawn in 
orange, arrow head points to the 3’end of the gene. CM(R) 
indicates the chloramphenicol resistance .F replicon (F 
plasmid). Picture made in VNTI 10 (Invitrogen). 
equal distribution of the vector after replication to the daughter cells. DNA fragments 
used to generate BACs usually have a size of 150-350 kilo bases (kb). 
The use of BAC-based transgenesis usually eliminates the problem of position 
effects that occur in classical transgenic mice. Furthermore as DNA fragments contain 
all the regulatory elements of the GOI, this usually leads to predictable transgene 
expression patterns. 
 To find BAC clones, which contain DNA fragments including the Mfge8 
locus (chromosome 7, 41.2 cM), we searched the national center of biotechnology 
information (NCBI) using their software clone finder. We found several clones 
containing the Mfge8 locus, but chose RP23-24N16 (BAC23), a clone containing a 
247kb sized genomic insert, which had been generated by insertion of a partial EcoRI 
digestion of C57Bl6 mouse 
genomic DNA and subsequent 
ligation with the BAC back 
backbone. RP24-246M19 
(BAC24 19), and RP24-
378M11 (BAC 24 11), were 
kept as alternative clones. 
In BAC 23, the Mfge8 
gene (15kb length) is 
localizing in the central area 
of the insert, ensuring that all 
regulatory elements are 
present (Fig. 30 and Fig. 31). 
The disadvantage of BAC 
technology is, that the big 
genomic fragments used to 
generate transgenics, 
frequently contain additional 
genes apart from the GOI. The 
generation of BAC transgenic mice might therefore result in their co-expression and 
generate unexpected phenotypes. BAC 23 contains the gene encoding for aggrecan 
(Acan), an extracellular matrix protein involved in axonal outgrowth, Hapln3 
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(hyaluronan and 
proteoglycan 
link protein 3), a 
protein with so 
far unknown 
function, as well 
as the first 2kb 
of Abhd2 
(abhydrolase 
domain 
containing 2), 
containing only 
parts of the non-
coding sequence (Fig. 31).  
 Due to their large size BACs contain a multitude of restriction sites, making a 
restriction digest approach to insert the GOI into the BACs impossible. Instead 
homologous recombination is the technique to insert a GOI at a site of interest in 
bigger plasmids (Fig. 32) (Johansson et al. ; Zhang et al. 1998). To enable 
homologous recombination, PCR based technique is used to flank the GOI with 50bp 
5’ and 3’ homology arms that are complementary to the target area on the BAC 
fragment. The PCR product and a plasmid encoding for the RED proteins essential for 
recombination are transformed into the E.coli containing the BAC. The RED proteins 
are Red, which functions as a 5’-3’ exonuclease, and Red, a single strand binding 
protein. In their presence the ends of the GOI-PCR product become single stranded 
DNA and undergo homologous recombination into the target site of the BAC. As the 
targeting cassette also contains an antibiotic resistance gene, BACs undergone 
recombination can be selected by growing E.coli in the presence respective antibiotic.  
Fig. 32 Scheme of events during homologous recombination 
Step 1 (upper row): the targeting cassette, containing the GOI as well as an 
antibiotic resistance gene, is added flanking homology arms of 50bp size by 
PCR. Step 2 (middle row): E.coli containing the BAC are transformed with a 
plasmid for the RED recombinases as well as with PCR product. BAC after 
undergoing targeted recombination into the Mfge8 locus (lowest row) 
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We planned to insert the targeting cassette at the translational start of Mfge8, 
at position 93bp in exon 1 and replacing the remaining exon 1, but leaving the other 
introns and exons unchanged (Fig 33). The targeting cassette consists of the GOI, a 3’ 
polyadenylation (polyA) sequence followed by the antibiotic resistance gene 
neomycin (NeoR). Furthermore, we replaced the Mfge8 translation start site 
(AGCATG) by the by the classical Kozak consensus sequence (ACCATG), this 
sequence is known to facilitate optimal translation initiation.  
Fig. 33 Scheme of the targeted Mfge8 locus 
The targeting cassette (in green) is inserted into the Mfge8 locus at exon 1 replacing the endogenous 
Mfge8 ATG at position 94 amino acids (aa). The targeting cassette contains the GOI, followed by the 
bovine sequence needed to add the Poly A tail, needed for stabilization and translation of the 
generated mRNA. NeoR is flanked by Flp recognition target sequences (FRT).  
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Verification of the BAC clones 
E. coli clones transformed with one of the three different BAC clones, BAC23, BAC 
24 19, or BAC24 11, were obtained from BACPAC resource center. The backbone of 
these constructs contained origin of replication and a chloramphenicol resistance gene 
(ChlorR). For each BAC, 2 subclones were picked from a chloramphenicol (Chlor) 
LB agar plate and expanded and PCRs performed to verify the clones. The presence 
of the Mfge8 exon 1 locus was first verified by PCR (Fig. 25). All BACs contained 
the Mfge8 exon 1 locus. Compared to the other clones BAC 23 should contain the 
biggest genomic insert and thus all regulatory elements of Mfge8. The other 
advantage of BAC 23 over the other clones is that the insert of BAC 23 had been fully 
sequenced and published. BAC 23 was therefore chosen to proceed with for targeting. 
To verify that the purchased BAC 23 not only contained the entire 250kb insert, PCRs 
with primers covering the intersection area between BAC insert and backbone were 
performed (BAC 23 start and end) (Fig. 34).  
Fig. 34 First verification of BAC 23 
Two clones of BAC23, BAC24 19 and 
BAC24 11, each, were tested for the 
presence of Mfge8 exon 1 (upper row) 
using flanking primers (401bp), Bl6 (WT 
mouse tail) as positive control, ---- water 
control. Insertion genomic DNA into the 
backbone was confirmed performing PCRs 
on the backbone/insertion intersection. 
BAC23 insertion start (BAC23 start 282bp 
(middle row)) and BAC 23 insertion end 
(BAC 23 end 257bp (lowest row)) 
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Cloning plasmids for the generation of targeting constructs  
For the generation of the different Mfge8 constructs, Cre (CrepANeofrt) and CreERT2 
(CreERT2pANeofrt) plasmids, with a 3’ polyA and a FRT flanked NeoR were 
obtained from Dr.Thorsten Buch and verified by sequencing (Fig. 35). FRTs (Flp 
recognition target) allow flippase (Flp)-mediated recombination of these sites and 
excision of the flanked area. Plasmids containing Prnp, Lta, Ltb and Tomato ORFs 
were sequenced and then subcloned into the CrepANeofrt to add the polyA and the 
FRT NeoR (Klein et al. 1998; Shaner et al. 2004; Heikenwalder et al. 2005). 
Subcloning was achieved by enzymatic cleavage and ligation, replacing the full 
sequence or parts of the Cre. The CrepANeofrt plasmid has single cut restriction site 
MluI at the end of the Cre gene, 5’ of the bovine polyA, as well as a single cut 
restriction site within the Cre gene, BstbI (=SfuI), and another motif recognized by 
KpnI 5’ of Cre gene. As the sequence for Lta and Prnp, already contained a KpnI 
cleavage, the combination BstbI and MluI was used as subcloning strategy. Ltb and 
tdTomato were inserted by KpnI/MluI digestion and ligation with the CrepANeofrt 
plasmid (Fig. 36).  
 
Fig. 35 Plasmids for the generation of Mfge8-Cre and Mfge8-CreERT2 
Scheme of the plasmids obtained for the generation of Mfge8-Cre and Mfge8-Cre ERT2 targeting 
cassettes. They contain Cre (left), and CreERT2 (right), respectively, with a 3’ bovine Poly A, and an 
FRT flanked NeoR (Neomycin), with a prokaryotic promoter (gb2) and a 3’ PolyA. Amp: ampicillin 
resistance gene  
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Fig. 36 Scheme of plasmids cloned to be used for the generation of the targeting cassette 
Substitution of Cre gene from the CrepANeofrt plasmid (A) by Prnp (B), Ltb (C), Lta (D), 
Tomato (E) using single cutting restriction sites, KpnI, BstbI, and MluI. Lta and Prnp are 
inserted using BstbI, as their sequence contains internal KpnI cutting site. Gb2 or gb2 
prokaryotic promoter, FRT (Flp recognition target), Amp ampicillin resistance gene, 
Neomycin NeoR. 
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The respective restriction motifs were added to the GOIs by PCR (Fig. 37 A). PCR 
products were cut from the gel and purified, the DNA content determined and the 
fragments 
digested with 
the respective 
pair of 
restriction 
enzymes. 
CrepANeofrt 
was digested 
with either 
combination of 
restriction 
enzymes and 
the backbone 
gel purified 
(Fig. 37 B). 
Inserts and 
backbone were 
ligated and 
transformed 
into E.coli, which were grown in ampicillin to select for ligated constructs. Single 
clones were expanded and proper insertion verified by sequencing.  
Generation of the targeting cassettes 
To generate the targeting cassette for homologous recombination primers were 
designed that they contain 50bp homology arms with the insertion region as well as 
25bp overlapping with the GOI. Only high quality, PAGE purified primers were used 
for the addition of homology arms. For the PCR, high fidelity and high speed DNA 
polymerases were employed. For all constructs except for Ltb, homology arms could 
be added. PCR products were gel purified and proceeded with for the homologous 
recombination (Fig. 38).  
Fig. 37 Cloning Lta, Ltb, Prnp, and tdTomato into CrepANeofrt plasmid 
Addition of BstbI/MluI restriction motives to Lta and Prnp, as well as 
KpnI/MluI motives to tdTomato, Ltb by PCR. Separation of PCR products by 
electrophoresis, DNA size markers (lane 1 and 2), (-) PCR without DNA (A). 
Tomato showed three amplified products, with the main band running at the 
estimated size of 1.4kb. (B) CrepANeofrt digested either with KpnI/MluI (3rd, 
4th lane) or SfuI/MluI (7th,8th lane), and run over agarose gel, shows the digested 
backbone and insert. 
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Homologous recombination 
For homologous recombination, BAC23 E. coli were first electroporated with the 
plasmid encoding for the Red/Redproteins and containing a tetracycline resistance 
gene (TetR) (Red/ET), and a thermosensitive origin of replication. (below 30°C). The 
expression of Red/Red mRNA is regulated by an L-arabinose-inducible promoter. 
E.coli containing the BAC and Red/ET were grown in the presence of L-arabinose 
before the constructs containing the homology arms were electroporated. During a 
further incubation step of 1-2h at 37°C, homologous recombination occurred, while 
the Red/ET plasmid was lost. The NeoR contained within the targeting cassette 
conferred antibiotic resistance for kanamycin (Kana). After 1-2h E. coli were 
positively selected for recombination on LB-agar plates containing Kana, single 
clones picked and tested for their insertion by PCR (Fig. 39; and data not shown). The 
absence of non-recombined BAC was further confirmed by PCR amplifying the 
Fig. 38 Addition of homology arms 
Targeting cassettes for the Mfge8 locus were generated by PCR 
amplification using primers containing 50bp of homology arms and 
25bp of annealing sequence of the specific insert containing the GOI 
as well as the FRT flanked neomycin. (A) Cre targeting cassette 
(3.7kb, upper bad), (B) Prnp targeting cassette (3.2kb, left), and 
tdTomato targeting cassette (3.9kb, right), (C) CreERT2 (4.4kb, left) 
and Lta containing cassette with homology arms (3.2kb, right). --- 
water control. 
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original Mfge8 exon1 locus (Fig. 40). 3 clones had inserted Cre, 2 tdTomato, 1 Lta, 3 
Prnp and 9 CreERT2 into the Mfge8 exon 1 locus. 
 
Fig. 39 PCR to test for insertion of targeting cassette  
To test the insertion of the targeting cassette into the Mfge8 exon 1 locus different PCRs were 
performed. Primer pairs used are indicated in the scheme in different colours. PCRs with primers 
annealing at the intersection of the 5’ region of the insertion locus were used to verify the 
recombination of the targeting cassette into the Mfge8 exon 1 locus. PCRs for the NeoR gene and the 
insertion end area are not shown (A) insertion of Cre (461bp) change picture in 5/13 clones, (B) 
tdTomato (1.8kb), (C) Lta (900bp) numbering of picture, (D) Prnp (1.1kb), (E) CreERT2 (2.1kb). B6 
(WT) and (---) water as negative controls.  
                                                                                RESULTS 
_____________________________________________________________________ 
                                                                                                                             82
 
 
Fig. 40 PCR to test for the removal of the endogenous Mfge8 Exon 1 locus  
PCRs with primers annealing upstream and downstream of the Mfge8 Exon1 locus were used to test 
whether the endogenous Exon 1 had been ablated during the targeting event (401bp). Though these 
primers still anneal, 5’ and 3’ of the targeting cassette, the segment to be amplified is too large to be 
amplified in this PCR. Clones that remain positive for Mfge8 exon 1 PCR have a contamination with 
non recombined BAC constructs (A) Cre targeting, clones 2.3, 4.1, 4.2 had undergone recombination, 
and no contamination with non-recombined BAC (B) Both tdTomato clones are negative for the 
endogenous Mfge8 Exon 1 (C) Lta clone 1.8 had lost the endogenous Mfge8 (D) Prnp clones 1.2, 1.3, 
1.5 had recombined properly (E) CreERT2 all clones had undergone insertion into the Mfge8 locus. 
Unrecombined BAC (ori), B6 (WT mouse tail DNA) positive control. --- water control.  
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Removal of the neomcycin resistance gene 
The targeting cassette of our constructs not only contained a prokaryotic promoter site 
(gb2) 5’ of the NeoR gene to allow the selection of BACs having undergone 
homologous recombination, but also the strong eukaryotic phosphoglucokinase 
promoter (pGK), which allows expression of the constructs in vitro, by transfection of 
mammalian cells and selection for NeoR. However, in transgenic mice, the presence 
of the pGK promoter in proximity to the GOI’s promoter, can lead to competition for 
transcription factors, resulting in aberrant GOI expression. We, therefore, intended to 
ablate the pGK/gb2 promoter and the NeoR, by recombination of the FRT sites 
flanking this area. For this purpose the 706-Flp-tet plasmid (Genebridges) was used. 
706-Flp-tet is a low copy number plasmid, whose replication is thermosensitive - thus 
the plasmid can be propagated below 30°C, but is lost at higher temperatures. It also 
contains a TetR, and a heat-inducible promoter (37°C), driving the transcription of 
Flp only at 37°C (Cox 1983). These characteristics allow the recombination of FRT 
sites, and at the same time guarantee the loss of the plasmid after the recombination 
event. E.coli containing the recombined BACs were electroporated with 706-Flp-tet, 
and selected for TetR. Single clones were picked and heat-induced over night in LB 
medium to allow recombination of FRT sites. Same amounts of cells were plated on a 
LB agar plate containing Neo/Chlor or Chlor only, to determine recombination 
frequency. The increase of E.coli colonies on plates containing Chlor only, indicated 
that NeoR had been successfully removed. For each targeted BAC, several clones 
were picked and expanded, and then split 1:1 and grown either in Chlor or Chlor and 
Neo. Clones which were unable to grow in Neo were tested for their loss of NeoR by 
PCR (Fig. 41). Furthermore, PCRs were performed to confirm that the GOIs had 
remained inserted at the insertion site (data not shown). 
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Fig. 41 PCR to test for the ablation of the NeoR gene  
Scheme indicating the annealing of NeoR primers before the recombination of FRT sites (left), after 
recombination (right) annealing sites are ablated. Clones, which were unable to grow in neomycin 
containing medium were verified by PCR for the loss of NeoR gene. In case of Prnp (1.2, 1.5), 
CreERT2 (CreE2 1.3) and tdTomato (1,2) each 3 FLP transformed plasmids were grown in presence 
or absence of Neo. Clones which had lost their ability to grow in presence of neo were tested by PCR 
for the loss of NeoR, not recombined clones were used as positive control, B6 (WT mouse genomic 
DNA) and --- water as negative controls.  
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Though Mfge8-Lta had undergone Flp-mediated recombination of the FRT sites (data 
not shown), we did not continue with the final verification steps. This was due to the 
fact, that Mfge8-Lta was meant to be co-expressed with Ltb driven by the Mfge8 
promoter, as stimulation of the LTR is mediated by the LT heterotrimer. 
However, the generation of the targeting cassette for Ltb had so far failed. We 
therefore focused on the completion of the Mfge8-Cre, Mfge8-CreERT2, Mfge8-
tdTomato, and Mfge8 Prnp. Clones, where the NeoR had been successfully removed. 
As BACs have a tendency to recombine while being propagated in E.coli, and any 
changes in the 
250kb might 
alter the 
expression 
pattern of our 
GOIs. To test the 
integrity of the 
BACs, DNA 
from multiple 
clones/construct 
was purified and 
subjected to 
restriction 
fragment 
analysis (RFA). 
Using enzymes 
which cut the 
BAC 20-30 
times, this 
resulted in DNA 
fragments of 1-50kb size. Fragments were separated by gel electrophoresis, the 
restriction pattern was compared to the original BAC clone, and verified that the 
obtained fragments matched the in silico size prediction (Fig. 42). RFA confirmed 
that certain BACs had undergone unwanted recombination events, these BACs were 
excluded from further analysis.  
Fig. 42 RFA of BAC constructs 
(A) Mfge8-Cre clones were digested with BssHII and restriction fragments 
compared to the original BAC. All Mfge8-Cre 4.2 clones, had an additional 
band at 12kb, suggesting that this clone had undergone additional unwanted 
recombination, clones 4.1 had retained integrity (marked with red box). (B) 
RFA analysis of Mfge8-Prnp, Mfge8-tdTomato and Mfge8-CreERT2 clones 
compared to original BAC by XmaI digest. Clones, which maintained 
integrity, are shown in red box. 
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Isolation and final verification of the DNA  
There are two main requirements for the DNA used for pronuclear injection into the 
oocyte: right quantity and high quality - there should be little contaminants, meaning 
other proteins or endotoxins derived from the E.coli, and little DNA degradation. 
Because BAC DNA is so large, the DNA is less stable than a small plasmid and can 
easily be sheared into small pieces. Special care has to be taken, and therefore, large 
orifice pipette tips were used during DNA preparation to reduce shearing forces.  
DNA maxipreps were prepared using Sigma Phase prep BAC DNA isolation 
kit, which allows the isolation of large DNA plasmids and includes repeated 
endotoxin removal steps. Maxipreps were prepared from Mfge8-Cre (3 clones 4.1.1, 
4.1.4, 4.1.9), Mfge8-Prnp (clone 1.5.1.2), Mfge8-tdTomato (clone 1.2.1), and Mfge8-
CreERT2 (clone 1.3.2.1). Isolated DNA was resuspended in injection buffer, 
containing the DNA stabilizing polyamines spermine and spermidine. A final 
verification of the constructs was done by PCR, sequencing and RFA (Fig. 43, 44, 
45). For the PCR primers were used, which anneal upstream of the Mfge8 exon1 as 
Fig. 43 Final verification of the GOI insertion into the BAC by PCR 
Primer pairs were used amplifying the area between Mfge8 exon 1 and intron 1 as indicated in the 
scheme, thus amplifying the Mfge8 locus of an unrecombined BAC (400bp), as well as of a 
recombined BAC, which has undergone FLP-mediated removal of the NeoR cassette. (A) PCR run on 
Mfge8-Cre clones 4.1.1-4.1.9 (1.8kb) and (B) on Mfge8-CreERT2 (2.7kb), Mfge8-Prnp (1.6kb), 
Mfge8-tdTomato (2.2kb). Original, unrecombined BAC and B6 (WT genomic DNA) served as 
positive controls for the endogenous PCR. --- contained no DNA All recombined BACs contained 
fragments of the right size and no contaminating unmodified Mfge8 exon 1  
                                                                                RESULTS 
_____________________________________________________________________ 
                                                                                                                             87
 
well as in the intron 1 of Mfge8, thereby amplifying the inserted construct 
approximately 100bp of the targeted area (Fig. 43). The PCR product was then 
isolated and sequenced. No mutations were found in Mfge8-Cre, Mfge8-Prnp, Mfge8-
CreERT2, Mfge8-tdTomato had an additional cytosine nucleotide in the intron 1 – 
however this should not result in an alteration of the expression, as it is positioned 
some hundred bp 3’ of the PolyA sequence. Detailed RFA with 2 different enzymes, 
SpeI and XmaI, was performed to verify the modification and the BAC integrity in 
the different constructs (Fig. 44, 45).  
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Fig. 44 Confirmation of Mfge8-Cre BAC integrity and modification by RFA  
2ug of Mfge8-Cre containing BAC and original BAC were digested in the presence of XmaI (A)or 
SpeI (B), DNA fragments separated by electrophoresis and pictures taken at different time points 
(left:latest time point; right: earliest time point). (A) right side shows the loss of the XmaI fragment in 
the recombined clones (red arrow; 1.6kb), and the appearance of a second 3kb band (green arrow; 
stronger intensity band) which proves the proper insertion of the Cre GOI. Remaining restriction 
fragments (A, B) were identical to the original BAC and the predicted fragment size. * indicates 
undigested plasmid. 
                                                                                RESULTS 
_____________________________________________________________________ 
                                                                                                                             89
 
All constructs were shown to have maintained integrity and proper insertion by RFA. 
The specificity of the insertion and an area of about 9kb around the insertion of the 
GOIs Prnp, CreERT2 and tdTomato, were furthermore confirmed by Southern blot 
using radiolabelled probes annealing 5’ and 3’ of the insert (Fig. 46). 
Fig. 45 Confirmation of Mfge8-CreERT2, -Prnp, -tdTomato integrity and modification by RFA  
2ug of BAC constructs and original BAC were digested in the presence of XmaI (A)or SpeI (B), DNA 
fragments separated by electrophoresis and pictures taken at different time points (left:late time point; 
right: early time point). (A) right side shows the loss of the XmaI fragment in the recombined clones 
(red arrow; 1.6kb), and the appearance of the new fragment (green arrow; CreERT2 (CE2) 3.9kb, 
Prnp (P) 2.5kb, tdTomato (T) 3.4kb. Remaining restriction fragments (A, B) were identical to the 
original BAC and the predicted fragment. * indicates undigested BAC. 
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Fig. 46 Southern blot analysis of Mfge8-Prnp, Mfge-CreERT2, Mfge8-Tomato 
(A) Scheme of the fragments that are generated by an enzymatic digest with AfeI of an unmodified 
BAC (left, upper row), a BAC with insertion of Prnp (right, upper row), CreERT2 (left, lower row) 
and tdTomato (lower row, right), the size of the fragments generated are indicated below the 
constructs, tdTomato contains 2 internal AfeI sites, resulting in the generation of 2 different fragments 
detected by the 5’ and the 3’ probe. (B) gel electrophoresis of the unmodified BAC (orig), Mfge8-
CreERT2, Mfge8-Prnp, and Mfge8-tdTomato after digest with AfeI. Arrows point to the construct 
specific fragments generated by the digest. (C, D) Arrows point to the construct specific fragments 
that are detected with the radiolabelled 5’ and 3’ probe, respectively. 3’ probe binds slightly 
unspecific, detecting additional fragments of the BAC. 
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DNA purification and pronuclear injection 
DNA was linearized by a single cutting enzyme and run over a sepharose column. 
The principle of sepharose separation is similar to gel electrophoresis: smaller 
fragments pass through the column matrix quicker than large ones do. The sepharose 
purification is thus used to eliminate degraded and bacterial DNA from the full length 
BAC construct and equilibrate the DNA in injection buffer used during this 
procedure. Collected fractions were analyzed by pulsed field electrophoresis, which 
allows the separation of high molecular weight DNA (20-several hundred kb). The 
early fractions contained smaller bacterial DNA and sheared DNA, while full length 
DNA was found in later fractions (Fig. 47A, 48).  
Mfge8-Cre fraction 8 (1ng/L) was used for injection into male pronuclei of 
approx. 200 fertilized oocytes derived. Subsequent embryo transfer resulted in the 
birth of 21 live F0 pups. Tail biopsies of all F0 animals were taken and assessed for 
the presence of the transgene (Fig. 47 B). Two female F0 mice were identified as 
positive for the Mfge8-Cre transgene. Transgene-positive founder mice were bred to 
homozygous R26R-lacZ Cre reporter mice. However, neither one of the two founder 
mice managed to transmit the transgene to their offspring (21 mice were screened, 
Fig. 47 C and data not shown) suggesting that both founders were mosaic animals 
incapable of transgene germline transmission. The pronuclear injection with new 
DNA had therefore been repeated.  
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Fig. 47 Pulse field electrophoresis of Mfge8-Cre, analysis of founder mice 
(A) Mfge8-Cre BAC was linearized with AscI, DNA purified over a sepharose column, and 22 
fractions à 500uL were collected and fractions 1-18 were run on 1.1% agarose gel. Fractions 5-7 
contained lower molecular weight DNA, while fraction 8 was enriched in full length plasmid. Fraction 
8 (red box) was used for pronuclear injection. (B) Pups generated after pronuclear injection were 
analysed for the presence of the transgene using Cre specific primers. 2/21 mice were positive for the 
transgene (founder 2 and 6). (C) Offspring from the 2 founders (5, 9 mice respectively) were tested for 
transgene insertion by PCR. None of the offspring carried the transgene.
                                                                                RESULTS 
_____________________________________________________________________ 
                                                                                                                             93
 
Fig. 48 Pulse field electrophoresis of Mfge8-CreERT2, Mfge8-tdTomato, Mfge8-Cre and Mfge8-
Prnp 
(A) Mfge8-CreERT2, Mfge8-tdTomato, Mfge8-Cre and Mfge8-Prnp BACs were linearized with 
MreI, DNA purified over a sepharose column, and 22 fractions à 500L were collected. Fractions 4-
17 of Mfge8-CreERT2 and Mfge8-tdTomato were run on 1.1% agarose gel (A, B). Fraction 12 of 
Mfge8-CreERT2 (1.9ng/uL) and fraction 11 of Mfge8-tdTomato (1.8ng/uL) contained mainly full 
length BAC and were used for pronuclear injection. (C) Mfge8-Cre and Mfge8-Prnp, linearized or 
linearized, sepharose purification fractions constructs (6-11). Sepharose purification resulted in 
degradation of the construct.  
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Fractions of linearized Mfge8-CreERT2, Mfge8-tdTomato, Mfge8-Cre and Mfge8-
Prnp obtained after sepharose column separation were analyzed by pulse field 
electrophoresis (Fig. 39). Mfge8-CreERT2 faction 12 was used for pronuclear 
injection (1.9ng/uL), for Mfge8-tdTomato fraction 11 was used (1.8ng/uL). Due to 
DNA degradation during the sepharose separation step of Mfge8-Cre and Mfge8-
Prnp, circular DNA was used for the injected into the pronucleus. 41 pups were 
received after injection of Mfge8-Cre into the pronucleus. PCR for Cre revealed that 3 
out of 41 mice were transgene positive (Fig. 49).The pronuclear injection of Mfge8-
Prnp yielded 50 pups, 7 were trangene positive (Fig. 50). We are currently waiting for 
the remaining pups derived from pronuclear injection of Mfge8-CreERT2, and 
Mfge8-tdTomato. 
 
Fig. 49 Mfge8 Cre founders 
Newborn mice derived from pronuclear injection of the Mfge8-Cre construct were analyzed for the 
integration of the transgene by PCR for Cre. 3/41 had insertion of the transgene (number 26, 36, 39). 
+ positive control. --- water control. 
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Fig. 50 Mfge8 Prnp founders 
Newborn mice derived from pronuclear injection of the Mfge8-Prnp construct were assessed for the 
integration of the transgene by PCR for transgene specific Prnp. 7/50 had insertion of the transgene 
(litter2: 9, 27 litter 3: 5, 7, 11, 12, 15). + positive control. --- water control. 
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DISCUSSION 
Mfge8 – a marker to study FDC-like cells  
The origin of FDCs has remained issue of a long lasting debate. Using in situ 
hybridization techniques for Mfge8, the RNA encoding for the FDC marker FDC-M1, 
I found that apart from mature FDCs, additional cells express this marker. They were 
localized within the B cell follicle, lining the marginal sinus, but were also to some 
minor extent within the T cell zone of WT spleens. Similar results were obtained from 
the analysis of WT LNs, where cells outside the B cell follicle expressed Mfge8. 
More detailed analysis of the spleens revealed that these cells shared additional 
markers with mature FDCs, such as BLC, ICAM-1, MAdCAM, and BP-3.While 
Mfge8 stained only very specific cell populations in the MS, BP-3 and ICAM-1 
showed a much broader expression pattern in the T cell zone and in case of ICAM-1 
also in the red pulp. I concluded from that that the Mfge8+ cells in the MS, though 
expressing follicular stromal cell markers, could represent a specific population, with 
characteristics of FDCs. These cells Mfge8+  cells were radioresistant, their 
maintenance depended on LTR signaling and they were derived from the stromal 
compartment after BM reconstitution experiments, supporting furthermore their 
similarity to mature FDCs. The progenitor of FDC so far had remained unknown, we 
therefore assumed these cells putative precursors and called them preFDCs. As the 
preFDCs were also producing factors such as BLC and ICAM-1, there was a high 
probability that they were also involved in the regulation of B cell attraction. Indeed 
we found that the dedifferentiation of preFDCs, by blocking the LTR signaling 
cascade, went hand in hand with a loss of MZ B cells. To finally prove that preFDCs 
are cells needed to establish the MZ B cell zone, conditional ablation of the preFDC 
population would be essential. This will be pursued using the Mfge8-Cre transgenic 
mice, crossed to the Cre-inducible diphtheria toxin receptor mice (iDTR). Why 
preFDCs produce Mfge8 remains an open question. In contrast to GCs, apoptosis in 
the MZ is not a frequent event. Other functions were so far attributed to Mfge8 - 
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Mfge8 is involved in cell-cell adhesion, e.g. in the epdidymis Mfge8 regulates the 
intercellular adhesion of epithelial cells in an integrin v dependent fashion. Mfge8 
was also shown to be present in exosomes, and could therefore regulate transfer of 
membranous particles, for example containing ICs, and could probably modulate the 
immune response. Another described function of Mfge8 is the facilitation of 
neovascularization, and Mfge8 is also present in fully developed vessels. Since the 
MS is part of the splenic vasculature, preFDCs secreting Mfge8 might regulate the 
local vascular function. So far no MZ defect was described in Mfge8-/- mice. This 
might be either due to overlapping functions with other molecules as it has been 
described for the adhesion molecules ICAM-1 and VCAM-1. Only the blockage of 
both will result in the loss of the MZ B cells. It might be interesting to analyze the 
migration of hematopoietic cells and the transfer of ICs in Mfge8-/- mice. The finding 
of cells with FDC characteristics further implied that we are dealing with the long 
searched precursors of FDCs. 
Cellular and molecular cues needed for putative precursors of FDCs  
In WT spleens preFDCs and mature FDCs were co-existent, and I wanted to 
determine the molecular and cellular cues they depended on. I therefore tested the 
presence of preFDCs in genetically modified mice, which lack mature FDCs. 
Surprisingly, the ablation of TNFR1 did not alter the presence of preFDCs, and mice 
lacking B cells (Rag1-/- and MTD) contained preFDCs, as well, indicating that only 
mature FDCs depend on these lymphocytes and signaling mechanisms. The majority 
of preFDCs, however, depended on LTR signaling or on B cells in combination with 
the common cytokine receptor gamma (Rag2-/-c-/-), though in their absence some 
cells expressing Blc and Mfge8 remained, which I termed proFDC. Interestingly, 
similar observations were made in LN development: even though the maturation of 
LNs needs the presence of LTs and B cells, the stromal organizer secreting BLC at the 
future LN site is independent of LTR activation (Eberl et al. 2004; van de Pavert et 
al. 2009). Upon influx of LTis, LTR signaling is induced, leading to the expansion 
of stromal organizer cell population, upregulation of chemokines, adhesion molecules, 
and lymphangiogenesis.  
That the defect in the generation of preFDCs seen in Rag2-/-c-/- was due to a 
deficiency in LTs was supported by the finding that spleens of these mice had reduced 
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Lta mRNA and that agonistic LTR stimulation using anti-LTR antibodies would 
lead to an increase in FDC-like cells present. I therefore conclude that the early 
proFDC is independent of LTR activation, B cells and the common cytokine 
receptor gamma chain (c), but expansion of proFDCs depends on them. In the 
absence of the c chain the signaling of different IL-Rs is abrogated and NK cells not 
generated. However, though NK cells were reported to produce LTs under certain 
conditions, I was surprised to see that the ablation of NK cells from Rag1-/- mice had 
no effect on the development of preFDCs. IL-7R signaling is also blocked in the 
absence of the c. LTis, which express the IL-7R, are reduced in number and their 
function impaired in IL-7R-/- and Rag2-/-c-/- mice. I found that Rag1-/- mice depleted 
from LTis, had significantly reduced numbers of preFDCs. I therefore conclude that 
LTis supply preFDCs with LTs needed for the induction and for the development 
from the proFDC stage. The splenic generation of proFDCs, preFDCs and FDCs is 
therefore highly similar to LN maturation – I observed that the same signaling and 
cellular mechanisms direct the discrete steps of development. 
Perivascular induction of FDCs  
In mice lacking all follicular structures (Rag2-/-c-/-), proFDCs cluster at perivascular 
sites in the spleen. Reconstitution with WT BM of Rag2-/-c-/- mice leads to the 
restoration of all hematopoietic cells and sources of LT and results in the development 
of B cell follicles. In this experimental setup I found that lymphocyte entry happened 
at sites where proFDCs were present and that the infiltration of blood cells resulted 
increased proFDC numbers at perivascular sites. Furthermore, concomitantly with the 
generation of follicular structures, Mfge8+ cells were lining the future MS area and 
present within the follicles, indicating that proFDCs including future FDCs originate 
from the same perivascular cell. The process of proFDC expansion upon 
reconstitution depended on LTR activation, most probably with B cells providing the 
LT ligands, as shown by BM reconstitution experiments with cells from Lta-/- mice. 
The study of neonatal spleen development confirmed that the perivascular expansion 
of Mfge8+ proFDCs happened simultaneously with the entry of lymphocytes at early 
postnatal stages. Unpublished results and previous studies suggest that FDCs are 
derived from a mesenchymal local cell. Our results furthermore indicated that they 
originate from a perivascular local cell. Perivascular Mfge8+Blc+ cells might be 
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important to control the local entry of the lymphocytes by chemokines like BLC. In 
addition we observed that during the white pulp development, Mfge8 RNA was 
restricted to perivascular sites, while Mfge8 protein was mainly found within the 
vascular structures (data not shown). This indicates that Mfge8 might have a role in 
the lymphangiogenesis. A role of Mfge8 in neovascularization was already described 
previously, where Mfge8 was reported to bind to integrin v/3 and v/5 of 
endothelial cells, resulting in phosphorylation of AKT and Erk and activation of the 
pro-angiogenic pathway (Silvestre et al. 2005). 
 
Pericyte origin and pericyte character of preFDCs 
Pericytes are perivascular cells, which ensheath the endothelial cells. They regulate 
vascular development, stabilization and maturation, lack of pericytes is perinatally 
lethal (Soriano 1994; Armulik et al. 2005). Pericytes, were furthermore shown to be 
rather undifferentiated cells, which can undergo adipogenesis, chondrogenesis, 
osteogenesis, and myogenesis (Dellavalle et al. 2007; Tang et al. 2008). Pericyte 
markers are SMA, NG2, and PDGFRI therefore assessed whether FDCs and 
preFDCs express any pericyte markers. Mature FDCs expressed no or little pericyte 
markers, however, co-localization of Mfge8 expressing preFDCs with the pericyte 
markers SMA and PDGFR was found. This indicates that preFDCs are still more 
pericyte like, and that they might reflect a transient form between the pericyte and the 
mature FDC. Though mature FDCs did not express any pericyte markers, we wanted 
to test whether FDCs still might have derived from pericyte cells. I used the pericyte 
reporter mouse line, Pdgfrb-Cre crossed to the Cre-reporter line Rosa26R lacZ and 
analyzed the expression in the spleen. I found that the expression of the reporter co-
localized with FDC markers. Thus FDCs must have expressed the pericyte marker 
during their development, which supports their perivascular, pericyte origin. 
 
Mfge8 expressing cells in organs  where FDCs can be generated 
ectopically 
FDCs can be generated ectopically in non-lymphoid organs during chronic 
inflammatory conditions. In mouse models ectopic FDCs emerge as a consequence of 
transgenic overexpression of in liver and kidney. We therefore tested whether Mfge8 
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expressing cells could be found in kidney and liver of WT mice. In the kidney, 
Mfge8+ cells were found in the glomeruli and lining the tubuli of the kidney. 
Interestingly, mesangial cells are located within the glomeruli. They are specialized 
pericyte cells, which also have phagocytic activity and were shown to ingest apoptotic 
cells (Cortes-Hernandez et al. 2002) They were furthermore shown to phagocytose 
immuneglobulins via their Fc-receptors (Sedor et al. 1987; Santiago et al. 1989; 
Santiago et al. 1991). Thus Mfge8 expressing cells in the kidney might be the 
glomerular pericytes, and Mfge8 might regulate the removal of proteins and apoptotic 
cells in this context. That further chronic activation of the LTR results in the 
generation of mature FDCs in this organ might imply that the local mesangial cells 
undergo differentiation. This question will be tackled using the Mfge-CreERT2 mouse 
line in combination with a R26R reporter mouse, to conditionally and permanently 
label mesangial cells and follow their fate during the development of kidney TLOs.  
In the liver of WT mice, I found expression of Mfge8 by oval cells, which 
happened in an LTR activation independent manner. Upon stimulation with 
agonistically acting anti-LTR antibodies, Mfge8 was found to be upregulated in oval 
cells, but also in a stellate pattern throughout the liver tissue, which might reflect 
another cell type, since there was no overlay with the oval cell marker to be found. 
Stellate cells are liver pericytes, and could be the cells upregulating Mfge8 upon 
LTR activation. I will examine the co-localization of Mfge8 with the pericyte and 
stellate cell marker SMA in agonist treated livers. Interestingly, LTR activation in 
non-matured lymphoid organs such as the Rag2-/-c-/- and in the liver, a non-lymphoid 
organ, results in the upregulation and appearance of Mfge8 expressing cells. These 
results support the model of a common FDC precursor in lymphoid and non-lymphoid 
tissues, whose development and maturation depends on LT signaling.  
Though lymphocytes can infiltrate many organs during chronic inflammations, 
not all organs do develop structured follicles with FDCs present. Are differences in 
the pericyte pool of a specific organ responsible for the outcome of TLO 
development? In case of adipogenesis it could be shown that only pericytes isolated 
from the adipocyte tissue contained precursor potential for white fat cells. To study 
different non-lymphoid organs with/without LTR activation for the presence of 
Mfge8+ cells might give insights into the ectopic development of TLOs.  
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Concluding remarks, an FDC maturation model and outlook 
While the signaling mechanism and the cells involved in the maturation of SLOs and 
TLOs are established, little is known about components tipping the scales for their 
very first induction. A recent publication suggests that neuronal endings give 
instructive signals to organizer cells at sites of future LNs, which, in turn, produce the 
B cell attracting chemokine BLC. BLC leads to the first recruitment of lymphoid 
tissue inducer cells, which results in upregulation of chemokines and 
lymphangiogenic factors and in the influx of lymphocytes (van de Pavert et al. 2009). 
In TLOs the first induction seems to be mediated by the antigen stimulating innate 
and adaptive immune responses which manifest in the influx of lymphocytes, the 
generation of follicular structures and the differentiation of the vasculature into HEVs 
regulating the influx of lymphocytes (Ludewig et al. 1998; Cupedo et al. 2004; Aloisi 
and Pujol-Borrell 2006).  
I suggest that at future sites of SLOs and TLOs, pericytes get an instructive 
signal, be it the presence retinoic acid released close-by neuronal endings in case of 
LNs (and probably also in the spleen) or a chronic exposure to an antigen stimulating 
the innate immune cells. Activation of these pericytes in turn leads to their 
upregulation of Mfge8 and BLC - in LNs they are now called stromal organizers, in 
the spleen I would like to introduce the term progenitor FDCs (proFDCs) - which 
leads to the recruitment of LTi cells and lymphocytes (Fig. 51, Fig. 52). Pericytes 
furthermore communicate with the vascular endothelial cells, upregulate adhesion 
molecules and lymphangiogenic factors. As a consequence of the positive feedback 
loop even more hematopoietic cells expressing high amounts of LTs arrive at the site 
of the developing lymphoid organ, activation of the LTR induces an expansion of 
Mfge8+Blc+ proFDC population, some of them might regulate the further 
angiogenesis, while others differentiate into precursors FDCs (preFDCs) in the 
marginal sinus and within the white pulp and mature FDCs. The progression from the 
proFDC stage to the preFDCs needs functional LTis and the presence of LTR 
ligands, but B, T and NK cells and TNFR1 activation are not essential. Presumably, 
the low levels of LTs and other factors produced by LTis suffice for the initial 
differentiation of proFDCs to preFDCs. Maturation of FDCs, is given only in the 
presence of B cells, which are providing high amounts of LTs and TNFR1 signaling. 
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I have no final proof for the succession line of proFDCs - preFDCs - mature FDC, 
though many observations support this hypothesis. To verify that proFDCs indeed 
differentiate into mature FDCs, I have started to generate BAC transgenic mice, 
which can be used to lineage trace FDCs. Mfge8-CreERT2 mice crossed to the R26R 
mice will be used to pulse Mfge8 expressing perivascular proFDCs by short term 
tamoxifen treatment at early postnatal stages, mature FDCs will be assessed for the 
expression of the reporter.  
Furthermore, PDGFR-Cre mice are currently bred to mice with a loxP 
flanked Ltbr locus. This will result in the conditional ablation of LTR in PDGFR 
expressing cells. FDC development requires LTR activation. If FDCs are indeed 
derived from PDGFR expressing cells, they will not obtain essential LTR 
activation and will be blocked in their development.  
I want to highlight that I do not believe that the only function of the pro- and 
preFDCs is the generation of mature FDCs, the use of the LTR decoy receptor to 
compete for endogenous LTR signaling, showed that MS preFDCs might function in 
the regulation of MZ B cell recruitment in the mature spleen. Therefore, preFDCs 
could regulate in an indirect way the TI-antigen response in the MS by cognate MZ B 
cells, but also the transfer of antigen by non-cognate MZ B cells into the germinal 
centers. 
Fig. 51 Scheme of FDCs 
development in the splenic follicle 
according to Mfge8 expression 
Perivascular cells (proFDCs, green) 
lining the central arteriole of the 
future splenic follicle. Upon influx 
of LTis, the increase in lymphotoxin 
present and generation of lymphoid 
follicles, perivascular proFDCs 
expand, are present within the 
follicular structure (1) as well as in 
the marginal sinus (2, preFDCs, 
orange). In the presence of 
TNFand B cells further 
differentiate into mature FDCs of 
the primary and secondary lymphoid 
follicles (3, red)  
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Fig. 52 Flow chart summarizing the FDC development stages  
Cell type, cell type subtypes on the left, location is indicated on the right. Low differentiated pericyte 
is at the beginning of the chart, the mature primary FDC at the end. Specific/novel cells markers, 
which define a certain development stage are indicated in bold and with a +. -/low: under detection 
limit 
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Materials and Methods 
Mice 
C57BL/6 were obtained from Harlan and Rorc(t)GFP/GFP from Jackson Laboratories 
(Eberl and Littman 2003). Rag1-/-, Rag2-/-c-/-, Tnfr1-/-, Lta-/-, Ltb-/-, Ltbr-/-, Mfge8-/- 
and C57BL/6 × 129Sv were maintained under specific pathogen free conditions 
(Mombaerts et al. 1992; De Togni et al. 1994; Alimzhanov et al. 1997; Futterer et al. 
1998; Goldman et al. 1998; Hanayama et al. 2004). Rag1-/- were intercrossed with 
Rorc(t)GFP/GFP to receive Rag1-/-Rorc(t)GFP/GFP and Rag1-/-Rorc(t)GFP/+. Spleens from 
Tnfa-/- and MTD were obtained from Rolf Zinkernagel’s laboratory (Kitamura et al. 
1991; Rothe et al. 1993). Pdgfrb-Cre+R26RlacZ+ and Pdgfrb-Cre-R26RlacZ+ spleens 
were obtained from Michelle Tallquist. All experiments were in accordance with 
Swiss federal legislation and had been approved by the local authorities. 
 
Generation of BM chimeras and immunizations 
BM recipients were lethally irradiated (950 rad). Donor BM was isolated by flushing 
tibias and femurs. Recipient mice received 107 donor BM cells intravenously (i.v.). 
Reconstitution efficiency was assed after 5 weeks by FACS analysis of blood 
leukocytes. 6 weeks after engraftment, mice were immunized intraperitoneally (i.p.) 
with 100 μg OVA (Sigma-Aldrich) in alum (Imject Alum; Thermo Fisher Scientific). 
2 weeks later, mice were boosted with the same dose of OVA. For reconstitution of 6-
8 week old Rag2-/-c-/- mice received 2x107 donor bone marrow cells without previous 
irradiation, mice were sacrificed and organs taken at indicated time points.   
 
Antibody and LTR-Ig treatment  
For all treatments 8-12 week old mice were used.  
To block LTR signaling mice were either treated i.v. 2x with 50g with m LTR -
mIgG1 (Biogen) or isotype control (MOPC 21, Biogen) during a period of a week or 
i.p. with 100ug once a week over a period of 4 weeks. For agonistic LTR treatment 
50ug of anti- LTR antibody (AC.H6, Biogen) or hamster IgG (Ha4/8-3.1, Biogen) 
were injected i.v. and mice sacrificed after 24h. Depletion of NK cells was performed 
using 100g anti-mouse NK1.1 (PK126, BD biosciences) or mouse IgG2a (G155-
178, BD biosciences) as isotype control injected i.v. weekly over a period of 3 weeks. 
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For depletion of MZ B cells WT mice were treated i.p. with 100g anti-integrin L in 
PBS (clone M17/4; eBioscience, rat IgG2a) in combination with either 100g anti-
VCAM1 (clone M/K-2; SouthernBiotech; rat IgG1) or 100g anti-integrin 4 (clone 
PS/2; SouthernBiotech, rat IgG2b). Isotype controls received 100ug rat IgG2a 
(eBioscience) in combination with either 100ug rat IgG1 or 100ug rat IgG2b(both 
SouthernBiotech). Mice were sacrificed after 4 days. 
 
Immunohistochemical analysis 
Cryosections were stained with hematoxylin/eosin or with antibodies against CD3 
(500A2), B220 (RA3-6B2) and CD21/35 (7G6, all BD bioscience) and detection was 
performed using respective AP- coupled secondary and tertiary antibodies in 
combination with Fast Red staining kit (Sigma). For immunofluorescent stainins 
splenic cryosections were acetone fixed, blocked in phosphate buffered saline (PBS) 
containing 0.5% BSA and 1% goat serum and stained with primary antibodies added: 
anti-Mfge8 (2422, Alexis Corporation or 18A2, MBL), anti-ICAM1-PE (3E2, BD 
bioscience), anti-SMA-PE (Sigma), anti-NG2, anti-MadCAM (MECA-367, BD 
bioscience), anti-MOMA1-FITC (Serotec), anti-ERTR9 (Bachem), anti-CD16/32 
(2.4G2, BD bioscience), anti-PrP (XN, made in our laboratory (Montrasio et al. 
2000)), anti-CD21/35 FITC (7G6, BD bioscience), anti-PDGFR (ebioscience) and 
the secondary antibodies anti-rabbit Alexa546, anti-rat Alexa594, anti-rat Alexa 647, 
anti-hamster Alexa 546, anti-hamster Alexa647, streptavidin Alexa 647 (all 
Invitrogen), counterstained with Dapi and analyzed by fluorescence microscopy 
(BX61, Olympus). 
 
In situ RNA Hybridization  
For generation of the RNA probe against Mfge8 and Blc, the open reading frame of 
Mfge8 and Blc was cloned into pBluescript II KS+ (Stratagene). After plasmid 
linearization RNA transcription was performed according to manufacture’s 
instructions (DIG RNA Labeling Kit, Roche) and the DIG (digoxigenin)-labeled RNA 
was hydrolyzed in carbonate buffer (40 mM NaHCO3, 60 mM Na2CO3). Frozen 
spleen sections (7 m) were thaw-mounted, air-dried and post-fixed in 4% 
paraformaldehyde in PBS followed by acetylation with 0.5% acetic anhydride in 0.1 
M triethanolamine. Hybridization was carried out in buffer containing 50% 
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formamide, 5x Saline Sodium Citrate (SSC) solution, 100 g/ml yeast t-RNA (Roche) 
and 5x Denhardt’s solution. For in situ RNA hybridization 200 ng/ml DIG-labeled 
RNA probe was added to the hybridization buffer and incubated at 72°C overnight. 
For detection either anti-DIG-AP antibodies were used and staining using BCIP/NBT.  
 
-Galactosidase Staining 
Frozen cryosections were air dried, fixed in 0.4% glutaraldehyde PBS, and 
permeabilized with 0.02% NP-40, 0.01% sodiumdeoxycholate, 2mM MgCl2 in PBS. 
Sections were incubated for 48h at 37°C shaking in the dark in staining solution 
(5mM FeKCN(II), 5mM FeKCN(III), 2mM MgCl2 in PBS containing 1mg/mL X-Gal 
(5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside)).  
 
FACS 
Single cell suspensions were made from freshly isolated spleens in PBS buffer 
containing 2% fetal calf serum (FCS), red blood cells lysis was performed in RBC 
lysis buffer (eBioscience). Fc-receptors were blocked with anti-CD16/32 antibody 
(2.4G2) and subsequently stained with following antibodies: NK1.1-APC (clone 
PK136), CD49b-PE (DX5), CD21/35-FITC (7G6), CD23-PE (B3B4). CD19-
Alexa647 (selfmade, Clone ID3), CD3-PE (500A2), CD4-Percp (RM4-5), 
biotinylated IL-7R (A7R34, eBioscience) and streptavidin-Alexa647 (Invitrogen). All 
antibodies were obtained from BD biosciences unless indicated. Cells were analyzed 
by FACSCalibur flow cytometer and FlowJo software. 
 
Quantitative PCR 
Total RNA from spleens was isolated using Trizol (Invitrogen) and chloroform 
extraction. 1g RNA was used to generate cDNA using QuantiTect Reverse 
Transcription Kit (Qiagen) according to the manufacturer’s instruction. Quantitative 
real-time PCR was performed using SYBR Green PCR Master Mix (Qiagen AG, 
Switzerland) on a 7900HT Fast Real-Time PCR System (Applied Biosystems) using 
default cycling conditions. Expression levels were normalized using Gapdh.  
 
Gapdh forward primer: 5’-CCACCCCAGCAAGGAGACT-3’  
Gapdh reverse primer: 5’-GAAATTGTGAGGGAGATGCT-3’  
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Mfge8 forward primer: 5’-ATATGGGTTTCATGGGCTTG-3’ 
Mfge8 reverse primer: 5’-GAGGCTGTAAGCCACCTTGA-3’  
Cd21 forward primer: 5’-CCCATAGTA CCAGGGGGATT-3’ 
Cd21 reverse primer: 5’-AGACTGGCAGAGCTGTGGGT-3’ 
Clusterin forward primer:  5’-CCAGTTCCCAGACGTTGATT-3’  
Clusterin reverse primer:  5’-AGCAGGGATGAGGTGTGGAG-3’ 
Blc forward primer:  5’-TCGTGCCAAATGGTTACAAA -3’  
Blc reverse primer:  5’- ACAAGGATGTGGGTTGGGTA-3’ 
Ifgbp3 forward primer: 5’-CGAGTCTAAGCGGGAGACAG-3’ 
Ifgbp3 reverse primer: 5’-TTGTTGGCAGTCTTTTGTGC-3’  
Cd30l forward primer: 5’-TGGCGATCATTCTGGTACTG-3’ 
Cd30l reverse primer: 5’-5’CAAGCCAGGGAATTGGACTA-3’ 
Lta forward primer: 5’-TCCACTCCCTCAGAAGCACT-3’ 
Lta reverse primer: 5’-AGAGAAGCCATGTCGGAGAA-3’ 
Tnfa forward primer: 5’-CGATGGGTTGTACCTTGTC-3’ 
Tnfa reverse primer: 5’-CGGACTCCGCAAAGTCTAAG-3’ 
 
BAC BAC RP23-24N16 
E coli containing the BAC RP23-24N16 were obtained from BACPAC Resources 
Center. It contained a 250kb insert of female mouse genomic DNA (C57BL/6J 
background). Vector insert was generated by partial digest using EcoRI and EcoRI 
methylase and ligated into the pBACe3.6 vector containing a ChloR. BAC clone had 
been fully sequenced and sequence published (NCBI).  
 
Generation of plasmids for the targeting cassette 
Plasmids containing Cre recombinase or CreERT2 followed by polyA sequence and 
FRT flanked neomycine resistance (NeoR) gene were obtained from Thorsten Buch. 
Subcloning of Prnp, tdTomato, Lta and Ltb open reading frame was done by addition 
of restriction motifs by PCR and ligation into Cre containing plasmid using Rapid 
DNA Ligation Kit (Roche) and BstbI, MluI, KpnI enzymes (NEB).  
 
Prnp forward primer: 5’gctctt-cgaaaccatggcgaaccttggcta 3’ (bold BstbI) 
Prnp reverse primer: 5’gctca-cgcgttcatcccacgatcaggaaga 3’ (bold MluI) 
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Lta forward primer: 5’gctctt-cgaaaccatgacactgctcggccg 3’ (bold BstbI) 
Lta reverse primer: 5’gctca-cgcgtctacagtgcaaaggctccaa 3’(bold MluI) 
Ltb forward primer: 5’gctcggtac-caccatggggacacggggactgcagg 3’ (bold KpnI) 
Ltb reverse primer: 5’gctca-cgcgt tcaccccaccatcaccgc 3’(bold MluI) 
tdTomato forward primer: 5’ gctcggtac-caccatggtgagcaagggcga 3’(bold KpnI) 
tdTomato reverse  primer: 5’gctca-cgcgtttacttgtacagctcgtcca 3’(bold MluI) 
 
Generation of the targeting cassettes 
Addition of homology arms was done using primers with approx. 25bp homology to 
the plasmid (Cre, CreERT2, tdTomato, Prnp, Ltb) and 50bp identical sequence of the 
Mfge8 Exon1 targeting area. For PCR amplification high fidelity DNA polymerase 
Phusion (Finnzymes) was used with Expand Long Template Buffer 3 (Roche), dNTPs 
(200M) and 0.5M primer in presence of 5ng plasmid. Optimal amplification was 
determined by gradient PCR thermocycler.  
 
Primers used to add homology arms: bold areas indicate homology area with Mfge8 
Exon 1 and Mfge8 Intron 1 in the forward, reverse primer, respectively 
Primer Mfge8–Cre forward  
5’tctcgagtcccagcatcagagcgcgtggaccttttcccgcgtcccgcaccatgcccaagaagaagaggaaggtgt 3’ 
Primer Mfge8–Ltb forward 
5’actctcgagtcccagcatcagagcgcgtggaccttttcccgcgtcccgcaccatggggacacggggactgcag 3’ 
Primer Mfge8–CreERT2 forward 
5’tctcgagtcccagcatcagagcgcgtggaccttttcccgcgtcccgcaccatgggcgccacgagtgatgaggttc 3’ 
Primer Mfge8–Lta forward 
5’tctcgagtcccagcatcagagcgcgtggaccttttcccgcgtcccgcaccatgacactgctcggccg 3’ 
Primer Mfge8–tdTomato forward 
5’tctcgagtcccagcatcagagcgcgtggaccttttcccgcgtcccgcaccatggtgagcaagggcgaggaggtca 3’ 
Primer Mfge8–insert reverse (for all constructs the same) 
5’gagaacttccgagcggcgggcagaacaggggcgaggccagagggactcaccttaagcttggaaaagctgg 3’  
 
PCR products were analyzed on a 1%agarose gel containing ethidiumbromide, gel 
extracted using GFX PCR DNA and gel extraction kit (GE healthcare).  
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Homologous recombination 
E.coli containing BAC RP23-24N16 were electroporated (1350V, 10uF, 600Ohms 
Eppendorf Electroporator 2510, 1mm cuvette) with Red/ET plasmid containing 
tetracycline resistance gene, a temperature sensitive origin of replication and a L-
arabinose dependent expression of Red recombinases (pSC101-BAD-gbaA 
genebridges). Clones were selected by growth on LB agar plates containing 3g/mL 
tetracycline (Sigma) and 15g/mL Chlor (Sigma). Single clones were then grown in 
1.4mL LB broth in the presence of Chlor only at 30°C until they reached an optical 
density at 600nm (OD600) of 0.2-0.3, then 50L 10% L-arabinose (Sigma) was added, 
temperature increased to at 37°C for 40min until to induce transcription of 
recombinase proteins, 200ng of targeting cassette containing NeoR and the homology 
arms were electroporated and selected on LB agar plates containing Chlor (15g/mL) 
and Kana (15g/mL; Sigma) and grown at 37°C to loose Red/ET plasmid. The loss of 
Red/ET plasmid was confirmed by the inability of these clones to persist in the 
presence of tetracycline containing LB broth. Recombination of cassettes into the 
Mfge8 Exon1 locus was confirmed by PCR and sequencing. 
 
Removal of NeoR by Flp recombinase 
Single recombined clones were grown 3h at 37°C in LB broth containing Chlor and 
Kana. Then electroporated with Flp plasmid (Flp706-tet genebridges), which contains 
a TetR gene, a thermosensitive origin of replication (lost at 37°C), as well as a heat 
inducible transcription of the Flp (induced at 37°C). E. coli were selected on LB agar 
containing tetracycline, Chlor and Kana. Single clones were picked and grown over 
night in 1mL LB broth (containing Chlor) at 37°C, which is leading to Flp mediated 
excision of NeoR gene, concomitant with a loss of the Flp-plasmid. 60-80% of the 
clones should have undergone recombination, which is assessed by growing same 
amounts of E.coli on LB agar plates containing, both, Chlor as well as Kana, or Chlor 
only and comparison of the total numbers in colonies grown. Due to recombination of 
NeoR, more E.coli were present on Chlor LB agar plates. 10 clones per construct 
were picked from Chlor containing agar plate, expanded in LB broth and tested for 
the loss of NeoR by PCR as well as by growing clonal replicas in LB broth containing 
Kana.  
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Restriction fragment analysis (RFA) 
2-3g of BAC DNA were digested in presence of XmaI, SpeI or BssHII (Roche 
Applied Bioscience) according to manufacturers instructions and separated on a 0.8% 
agarose gel (in 1x Tris acetic acid buffer (TAE)) by electrophoresis at 30V for up to 
48h. Lambda Mix Marker 19 (Fermentas) and bench top 1kb ladder (Promega) were 
used as size markers. 
  
DNA preparation and linearization for pronuclear injection 
BAC DNA was extracted from 1L E.coli culture in LB broth containing 15g/mL 
Chlor using the Phase prep BAC DNA isolation kit (Sigma). After purification, DNA 
was air-dried and resuspended in injection buffer (10mM Tris pH7.5, 100mM NaCl, 
0.1mM EDTA, 30M spermine, 70M spermidine) and stored at 4°C. 80g of BAC 
DNA was linearized using MreI (NEB) at 37°C in a total volume of 500L. The 
enzyme was heat inactivated at 65°C, and Heat inactivate enzyme 65°C 20min. Keep 
at 4°C, 400L of sterile filtered injection buffer and 20uL 6x DNA loading dye 
(Fermentas) added. 
 
Sepharose column and pulse field electrophoresis 
A sepharose column was created using a 5mL serological pipette (Sepharose CL-4B; 
Bioconcept). Therefore 11mL of sepharose was mixed with 5mL of injection buffer 
(10mM Tris pH7.5, 100mM NaCl, 0.1mM EDTA, 30M spermine, 70M 
spermidine), degassed and applied onto the column. The column was equilibrated 
with 30mL injection buffer, then the heat-inactivated linearized BAC DNA in 
injection buffer containing DNA loading dye applied onto the column and 22 
fractions of a volume of 500L eluted. DNA concentration and purity determined 
(nanodrop; Thermo scientific) and fractions run and separated by pulsed field 
electrophoresis in a 1.1% pulse field agarose (SIGMA) gel 0.5x Tris Borat EDTA 
buffer (TBE). As a molecular weight marker MidRange II PFG marker (New England 
Bioslabs) was used. Gel was poststained in EtBr containing 0.5xTBE buffer.  
 
Pronuclear injection 
B6D2F1 female mice were hormonally superovulated with 5 IU of Pregnant Mares 
Serum Gonadotropin and 5 IU of Human Chorion Gonadotropin i.p.. The 
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superovulated females were with B6D2F1 hybrid males. The next morning, fertilized 
one-cell eggs were scratched from the oviduct into M2 medium (Sigma). Cumulus 
cells were removed from the eggs with hyaluronidase (300 units/ml, Sigma); then the 
eggs were washed free of debris and enzyme. For injection, the eggs were transferred 
to a microinjection chamber in M2 medium and overlaid with oil. Eggs were 
sequentially held in place by a blunt pipet (outside diameter, 100 um) while the tip of 
the injector pipet was inserted through the zona pellucida and vitellus and into one of 
the pronuclei. The DNA solution (1-2ng/ul in injection buffer) in the injector pipette 
was slowly discharged into the pronucleous until a 30% distension of the pronucleus 
was observed. After injection the eggs were transferred M16 medium (Sigma) and 
cultured at 37°C for few hours, damaged cells were sorted out and the remaining ones 
transferred into the oviducts of pseudopregnant, random-bred CD1 mice. 
 
Primers used for verification of BAC clones 
BAC backbone PCRs 
Primer BAC backbone/insert start forward: 5’ aaggagctgactgggttgaa 3’ 
Primer BAC backbone/insert start reverse: 5’ ctgtctgcaccctccttctc 3’ 
Primer BAC backbone/insert end forward: 5’ tggcacttcactctttgacg 3’  
Primer BAC backbone/insert end reverse: 5’ cgatcctcccgaattgacta 3’ 
 
Mfge8 exon 1 locus PCR 
Mfge8 Exon 1 forward: 5’ CACTTCAGCCCTCCCTCTTC 3’ 
Mfge8 Exon 1 reverse: 5’ CACGTTCGCCTCTCCTACC 3’ 
 
NeoR PCR 
NeoR forward: 5’ gatcggccattgaacaagat 3’ 
NeoR reverse: 5’ gctccaatccttccattcaa 3’ 
 
Insertion start PCR (Mfge8 Exon1 to GOI STOP codon) forward primer in 
combination with GOI specific  reverse primers 
Mfge8 Exon 1 forward: 5’ CACTTCAGCCCTCCCTCTTC 3’  
Cre insert reverse: 5’ GACCGCGCGCCTGAAGATAT 3’ 
CreERT2, tdTomato, Prnp, Lta: reverse: 5’ AGGCTAGAACTAGTGGATCT 3’  
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Insertion end PCR (second FRT to Intron 1) 
FRT2 insert fwd: 5’ GCTGAAGAGCTTGGCGGCGAAT 3’  
Mfge8 Exon1 reverse 5’ CACGTTCGCCTCTCCTACC 3’  
 
Southern blot analysis 
For the generation of the probe, PCRs using phusion polymerase were performed with 
following primer pairs 
 
5’ Probe 
Primer forward: 5’ gctcagcaaatgctttaccc 3’ 
Primer reverse: 5’ agcatgctggagaccctaga 3’ 
 
3’ Probe 
Primer forward: 5’ cttgtcctacgcctttcagc 3’ 
Primer reverse: 5’ tgtcaagcattgcagagtcc 3’ 
 
PCR products were purified over gel and via GFX colum (GE healthcare). 
1g of BAC DNA was digested with AfeI (NEB), DNA separated over 0.8% agarose 
gel by electoporesis. Gel was rinsed in double distilled water (ddH20), incubated in 
0.2M HCl, washed in ddH20, transferred into denaturing buffer (0.5 M NaOH), and 
neutralized in 0.5M Tris-HCl pH7.4 and transferred onto Hybond N+ membrane (GE 
healthcare) by capillary transport in 20xSSC buffer over night. DNA transferred onto 
nitrocellulose membrane is crosslinked by exposure to UV. The nitrocellulose blot 
was preincubated in hybridization solution for 2h 68°C (QuickHyb hybridyzation 
solution; Stratagene). The radioactively labelled probe was generated according to 
manufacturer’s instructions, using previously purified PCR fragments for 5’/3’probe 
and radioactive 32dCTP 3000Ci/mmol (Stratagene KIT Prime-It II random primer 
labelling kit). Probe was purified using GFX column and eluted in 50L TE buffer 
pH8, 100L salmon sperm DNA 10mg/mL (Stratagene) added, and denatured 2min 
95°C and resuspended in 1mL hybridization solution, which was added to rotating 
flak containing 60mL hybridization solution and the Southern blot and incubated for 
4h at 68°C. Membrane was washed in different concentrations of SSC buffer 2xSSC 
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0.1% SDS and 0.2xSSC 0.1% SDS at 68°C and the phosphoimager screen exposed 
for 24h to the membrane, for detection Fuji phosphoimager was used. 
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